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ABSTRACT 
Aims 
The aim of this thesis is to develop a staff-administered behavioural pain assessment tool for 
older persons with dementia, to test the instrument with respect to reliability and validity, 
and to use it in the clinical setting of an entire nursing home (NH) population. 
 
Methods 
In Paper I, the development of the Mobilization-Observation-Behaviour-Intensity-Dementia 
(MOBID) Pain Scale was described. In MOBID, the assessment of inferred pain intensity 
was based on the patient’s pain behaviour in connection with standardized, active guided 
movements of different body parts. The internal consistency and inter-rater reliability of pain 
behaviour indicators and pain intensity scores were tested through bedside investigation and 
video recordings of 26 patients with severe dementia. Face validity was discussed by a focus 
group. Different aspects of construct validity were investigated.  
Paper II documented the extended testing of the intra-rater and inter-rater reliability of the 
pain behaviour indicators and pain intensity scores of the MOBID Pain Scale by three 
external raters, using video recordings, concurrently and independently on days 1, 4 and 8.  
In order to also assess pain from internal organs, the head and skin, an extended instrument, 
the MOBID-2 Pain Scale, was presented in Paper III. It comprised the original MOBID, 
renamed MOBID-2 Part 1, and MOBID-2 Part 2, which registered pain behaviour related to 
internal organs, the head and skin. Monitored over time, caregivers’ observations were 
registered on pain drawings and inferred into pain intensity. Finally, overall pain intensity 
was assessed, including all observations registered in Parts 1 and 2. The internal consistency 
of the comprehensive MOBID-2 was examined for 77 patients. Furthermore, the inter-rater 
and test-retest reliability of pain behaviour indicators, pain drawings and pain intensity 
scores were tested. Arguments for face, construct and concurrent validity were added when 
pain scores from nurses using MOBID-2 were correlated with physicians’ clinical 
examinations and other pain variables.  
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Paper IV was a cross-sectional study exploring the relationship between severity and  
diagnoses of dementia and the use of pain medication and other parameters of pain measured 
using pain intensity scores from MOBID-2 in 181 NH patients. 
                                         
Results 
The results of Paper I suggested that registration of pain behaviour indicators during 
standardised movements, as measured by the MOBID, can be used reliably to disclose pain 
intensity inferred by nurses in elderly persons with dementia. Internal consistency of the 
MOBID items was found to be high (=0.90). The inter-rater reliability of inferred pain 
intensity scores was high to excellent (ICC=0.70-0.96), but varied between poor to excellent 
for individual pain behaviour indicators (=0.05-0.84). Arguments for construct validity 
were indicated, as the MOBID Pain Scale revealed significantly more pain than did pain 
scores during regular morning care. Video observation demonstrated higher pain intensity 
than bedside scoring. The pain intensity scores were highly correlated with the number of 
observed pain behaviour indicators. Finally, the overall pain intensity score was more 
associated with the highest pain score among the test items than with the mean score of all 
items.   
As demonstrated by Paper II, facial expression of pain was most commonly observed, 
followed by pain noises and defence. Using video recording, inter-rater reliability was 
highest for pain noises, followed by defence, and facial expression (=0.44-0.92, =0.10-
0.76, and =0.05-0.76, respectively, on day 8). Of the movements, mobilisation of arms and 
legs was rated most painful. The intra-rater and inter-rater reliability of the overall pain 
intensity scores was very good, ICC(1,1) ranging from 0.92 to 0.97 and 0.94 to 0.96, 
respectively. As opposed to observed pain behaviour, the reliability of pain intensity scores 
tended to increase on repeated assessment. It was suggested that the overall pain score was 
based more on interpretation of the most pain provoking movement during assessment than 
on the total number of observed pain behaviour indicators. 
Using the MOBID-2 Pain Scale, the prevalence of any pain in patients with severe dementia 
was 81%, with predominance in the musculoskeletal system, as demonstrated in Paper III. 
Most frequent and painful was mobilising of the legs and arms (Part 1). Pain in the pelvis 
and/or genital organs was frequently observed in MOBID-2 Part 2. The internal consistency 
of the whole scale was highly satisfactory (=0.82-0.84). Moderate to excellent inter-rater 
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and test-retest reliability was demonstrated for pain behaviour indicators (=0.44-0.90 and 
=0.41-0.83) and pain drawings (=0.46-0.80 and =0.48-0.93). Moderate to excellent inter-
rater and test-retest reliability (ICC=0.80-0.94 and ICC=0.60-0.94) was shown for pain 
intensity scores. The inter-rater and test-retest reliability for the overall pain intensity score 
was excellent (ICC=0.92 and ICC=0.94). Arguments for concurrent validity were indicated, 
as the overall pain intensity of MOBID-2 as observed by primary caregivers was correlated 
with physicians’ clinical examinations and pain variables. Indication of construct validity 
was provided, as both Part 1 and Part 2 were satisfactorily correlated with the overall pain 
score. Part 1 was more highly associated with the overall pain score, suggesting that pain 
behaviour occasioned by standardised movements may represent a more concrete pain 
concept than the observation of pain from internal organs, the head and skin, monitored over 
time. 
Paper IV indicated that patients with severe dementia have similar intensity, diagnoses and 
locations of pain to patients in other stages of dementia. Pain intensity measured by MOBID-
2 scoring did not differ between diagnostic groups of dementia. Patients with dementia who 
received opioids were more likely to demonstrate higher pain intensity scores than mentally 
healthy controls receiving opioids. It was suggested that these patients received less pain 
relief than they needed. The isolated increase of opioids may be limited by the high 
prevalence of ICD diagnoses and opioid side effects. The patients’ multi-morbidity and lack 
of communication require a comprehensive approach to pain assessment and treatment in a 
multidisciplinary perspective. 
 
Conclusions 
The MOBID-2 Pain Scale is based on patients’ pain behaviour in connection with 
standardised active, guided movements of different body parts (Part 1), and pain behaviour 
related to internal organs, the head and skin (Part 2). Research evidence was provided that 
lent credibility to MOBID-2 as a reliable and valid nurse-administered assessment tool for 
inferred pain intensity. Using MOBID-2 in a cross-sectional study, it was suggested that 
patients with severe dementia and mixed dementia are at great risk of suffering from severe 
pain. 
Validity testing of a behavioural assessment tool is difficult, because the pain scores are 
indirectly observed and inferred by proxies (nurses). Future research should include 
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extended testing of concurrent validity, comparing the MOBID-2 Pain Scale with other 
observational pain tools for patients with dementia. Future research should also explore the 
prevalence of pain in Norwegian NHs, as the findings presented in this thesis were based on 
data from only one NH. Implemented in a quality improvement programme, the use of the 
MOBID-2 Pain Scale may be an important contribution to improving pain assessment and 
treatment in NH patients. 
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INTRODUCTION  
Advanced age is associated with increased prevalence of dementia, often combined with pain. 
Although elderly persons tend to have more painful diseases, they have been found to report 
less pain. They receive fewer analgesic drugs than their younger counterparts. With impaired 
cognition, patients’ ability to report pain decreases, leading to the interpretation by health care 
professionals that elderly persons with dementia have less pain complaints than mentally 
healthy controls. Thus, when elderly adults in pain also have severe dementia and reduced 
communicative abilities, they are at high risk of not being properly diagnosed and treated for 
pain, which is a major challenge in NHs. 
In response to the strong need for improvement in pain assessment and pain management in 
patients with dementia, several pain behavioural scales have been developed and reviewed. 
Interestingly, these scales do not systematically assess pain from the musculoskeletal system, 
and other types of pain, such as pain originating in internal organs, the head and skin. 
This thesis is about the development, and reliability and validity testing of the Mobilisation-
Observation-Behaviour-Intensity-Dementia (MOBID-2) Pain Scale. The MOBID-2 Pain 
Scale is a two-part nurse-administered pain assessment tool for patients with dementia, 
assessing pain from the musculoskeletal system, as well as internal organs, the head and skin.  
Moreover, this thesis aims to demonstrate the complexity of the psychometric property testing 
of a behavioural pain scale in patients with dementia, also shown in Figure 1. A valid and 
reliable pain scale is a prerequisite for improving pain assessment and management. The 
complexity of this topic is expressed in several factors, such as the nature of pain, different 
stages and diagnoses of dementia, staff conditions, the proxy rating process and ethical 
considerations.  
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STAFF
Competence
Awareness
MOBID-2 Pain Scale
Part 1: Pain from musculoskeletal system
Part 2: Pain from internal organs, head and skin
PAIN
Diagnoses
Location
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Figure 1. Complexity of the psychometric properties of the behavioural pain scale, the MOBID-2 Pain 
Scale Part 1 and 2, in patients with dementia as observed by nursing home staff 
 
The importance of relating neuropathology to pain in dementia has been emphasised earlier. 
Clinical studies on pain include both the “demented elderly” and the “cognitive impaired 
elderly” patients without more detailed information on the causes of their disorders. 
Information of the cause of the dementia is important, because it is related to the pathology 
and to possible changes in the patients’ pain. The MOBID-2 Pain Scale was used to explore 
the relationship between pain intensity and the use of pain medication in NH patients in 
different stages of dementia and with different dementia diagnoses.  
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BACKGROUND 
DEMENTIA 
The prevalence of dementia 
The rapid ageing of the population is unique in the history of mankind. This development 
represents challenges in terms of social justice and security, policy and health care, and the 
necessity of scientific research. One central challenge in connection with these dramatic 
demographic changes is the provision of care for the frail elderly with dementia. In prevalence 
studies of dementia, it is estimated that 24 million people worldwide have dementia today, 
with 4.6 million new cases of dementia every year, and the number affected is expected to 
double every 20 years, reaching 81 million by 2040 (Ferri et al., 2005). The rate of increase of 
Alzheimer’s disease and related dementias in developed countries is forecasted to be 100% 
between 2001 and 2040, but more than 300% in India, China, and Asia. In Norway, the 
number of people with dementia is approximately 70,000, and in Norwegian NHs more than 
80% of the patients are judged to have dementia (Selbaek et al., 2007). 
 
Alzheimer’s disease  
Dementia refers to a clinical syndrome that has many causes (Friedland and Wilcock, 2000; 
Mahlen, 2003): a) neurodegenerative diseases (Alzheimer’s disease (AD) (50-60%)), Lewy 
body diseases (DLB) and frontotemporal dementia (FTD) (15-20%)) 
b) vascular dementia (VaD) (20-30%) 
c) secondary dementia, e.g. due to alcohol, tumours.  
Dementia is defined as an acquired impairment of intellectual and memory functioning, which 
not only occurs in association with disturbances at the conscious level. By definition, these 
patients must have memory disturbances as well as defects in other mental abilities, such as 
abstract thinking, awareness, personality, judgement, language and neuropsychological 
disorders, severe enough to cause functional impairment (Engedal and Haugen, 2006; 
Reisberg, 2006).  
The most common cause of dementia in the United States and in Europe is Alzheimer’s 
disease, which is defined by pathological changes in the brain, such as neurofibrillary tangles, 
neuritic plaques, amyloid infiltration of vessel walls, granulovascular degeneration, and 
Hirano bodies (Tolnay and Probst, 2002; Hodges et al., 2004; Pantoni et al., 2006). There is 
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also a loss of neurons and loss of synaptic arborisation. These abnormalities are most severe 
in the medial basal temporal cortex (hippocampus and amygdale), the basal forebrain, and in 
the posterior lateral parietal and temporal cortices (den Heijer et al., 2006; Smith et al., 2007; 
McHugh et al., 2007). 
Another common cause of degenerative dementia is Lewy body diseases, manifested as 
dementia with Lewy bodies and dementia associated with Parkinson’s disease. These 
syndromes are characterised by dementia accompanied by Parkinsonism, visual 
hallucinations, fluctuating cognition and sleep disturbances (Emre, 2006; McKeith, 2007). 
 
Vascular dementia 
Age is an important risk factor for strokes, with prevalence increasing to 1.4% for people aged 
75 and above (Khaw, 1996). Infarctions, in which brain tissue is deprived of blood, and 
haemorrhages are the two major pathological processes. About 85% of acute strokes are due 
to occlusion of a cerebral artery by primary thromboses or occlusion of the vessel by an 
embolus (Bruun Wyller, 2003). 
Before Alois Alzheimer provided the histopathological description of Alzheimer’s disease in 
1902, Otto Binswanger (1894) described Binswanger’s disease caused by ischemia to the 
white matter substance (Friedland and Wilcock, 2000). It was regarded as a rare form of 
dementia, with slowly progressive intellectual impairment, and recurrent stroke-like events. 
At about 24% of the patients, a stroke is one of the most common diagnoses in the NH 
(Becker et al., 2003), causing long-term care challenges such as dementia, spasticity and 
contractures, epilepsy, depression, incontinence, aphasia, personality changes and pain 
(Evans, 2000). 
VaD or multi-infarct dementia is the second most common cause of dementia in the Western 
countries (Friedland and Wilcock, 2000). To estimate the exact prevalence of VaD is difficult, 
as different diagnostic and pathological criteria have been used in different studies, and some 
investigators believe that VaD may be over-diagnosed, while others believe that it is under-
diagnosed (Brust, 1988). However, infarction of the brain increases the risk of dementia nine 
fold (Tatemichi et al., 1992) by injury to the hippocampus, thalamus, or mesencephalon.  
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Mixed dementia (Alzheimer’s disease & vascular dementia) 
VaD has to be differentiated from other causes of dementia. The most difficult differential 
diagnosis is VaD accompanying AD (ADVaD), because (a) VaD can follow a slow 
progressive course in almost half of patients, and (b) vascular risk factors and cerebrovascular 
diseases may accompany AD, and (c) it is difficult to disentangle the relative importance of 
vascular and degenerative factors, and to determine the exact role of vascular lesions seen in 
neuro-imaging (Amar and Wilcock, 1996). Although, the diagnosis is often made at the post-
mortem examination, VaD is estimated to coexist with AD in about 10% to 15% of patients 
(Friedland and Wilcock, 2000).  
 
PAIN 
The neurobiology and psychology of pain  
In the Taxonomy Committee of the International Association for the Study of Pain (IASP), 
Lindblom et al. (1986) defined pain as: ‘an unpleasant, sensory and emotional experience 
associated with actual or potential tissue damage, or described in terms of such damage. Pain 
is always subjective. Each individual learns the application of the word through experiences 
related to injury in early life. Pain is a sensation in a part or parts of the body, but it is also 
always unpleasant and therefore an emotional experience. Unpleasant abnormal experiences 
(dysaesthesiae) may be pain but are not necessarily so because, subjectively, they may not 
have the usual sensory qualities of pain. Many people report pain in the absence of tissue 
damage or any likely pathophysiological cause; usually this happens for psychological 
reasons. There is usually no way to distinguish their experience from that due to tissue 
damage. If they regard their experience as pain, it should be accepted as pain.’  
 
Pain related to nociceptive activation 
The centre of pain processes is the integrated model of pain registration by pain receptors 
(nociceptor): a sensory stimulus involves receptor activation (transduction), the relaying of 
information from the periphery to the central nervous system (transmission), and neural 
activity that leads to pain transmission (modulation) (Dahl and Kehlet, 2006). While a number 
of disorders may cause pain, two types of conditions are part of somatic pain pathogenesis: 
nociceptive and neuropathical. Nociceptive pain is associated with tissue damage and a 
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normal nervous system (e.g. pain associated with osteoarthritis), while neuropathical pain is 
associated with nervous system dysfunction (e.g. diabetic neuropathy or post herpetic 
neuralgia). These two types of pain frequently coexist. 
Nociception, however, is not synonymous with pain; nociception may be necessary for pain to 
occur, but it is not sufficient to account for pain as a clinical presentation (Turk and Okifuji, 
1999). Nociception is a physiological phenomenon, whereas pain is a perceptual one that 
involves higher central nervous mechanisms and psychology. The patient’s pain perception 
and experience is individual due to several central pain components involving cognitive, 
behavioural, affective and hormonal factors. These qualities are related to the sensory-
discriminative, motivational-affective, cognitive-evaluative, and autonomic-neuroendocrine 
features, of the lateral and medial pain system (Melzack, 1999; Almeida et al., 2004).  
The lateral pain system represents sensory-discriminative pain modulation. The spinothalamic 
tract, originating in the dorsal horn, mediates the nociceptive stimuli to the lateral thalamus, 
and activates the primary and secondary somatosensory cortices, the parietal operculum, and 
the insula. The recognition of pain localisation, the intensity, duration and nature of 
nociceptive stimuli and the pain threshold are dependent on the lateral pain system being 
intact, especially the parietal operculum (Scherder et al., 2003a). 
The medial pain system represents the cognitive-evaluative (attention), the motivational-
affective (affective reaction), the memory (amygdalae, hippocampus) and the autonomic 
responses (hormones parasympathetic/sympathetic nervous system activation). Tissue damage 
or damage to the central or peripheral neural system will not always result in overt pain 
behaviour or suffering. Pain of short duration may have only a brief impact and no long-term 
consequences. Chronic pain, on the contrary, may lead to suffering, pain behaviour and 
substantial physical, psychological and social consequences for the patient, and his or her 
relatives. 
 
Pain related to viscera  
Compared to nociceptive pain, which is more easily localised and characterised as distinct 
sensations, visceral (vegetative) pain may be diffuse and poorly localised, typically referred to 
somatic sites, with stronger emotional and autonomic reactions (Bielefeldt and Gebhart, 
2006). The viscera are unique in that each organ, through thoracic, abdominal, and pelvic 
viscera, receives nerves from the autonomous nervous system, either vagal or spinal nerves or 
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pelvic and spinal nerves (sympathetic or parasympathetic). Visceral afferent fibres are 
contained in nerves that terminate in the spinal cord, except those in the vagus nerve, which 
terminate in the brain stem and innervate most internal organs of the thoracic, abdominal, and 
pelvis viscera. Autonomous afferents are important for chemo-nociception, affective 
dimensions and unpleasantness. 
 
Pain mediators 
A number of chemicals that mediate or facilitate the inflammatory process, including 
bradykinin, prostaglandin, leukotrien, serotonin, histamine, substance P, thromboxane, 
platelet-activating factor, adenosine and adenosine tri-phosphate (ATP) are central in the pain 
process. Cytokines (interleukins), tumour necrosis factor and neurotrophins are also generated 
during inflammation. Some agents can directly activate nociceptor receptors (e.g. vanilloid, 
cholinerg, GABA, somatostatin and opioid-receptors), while others act indirectly (McMahon 
and Jones, 2004; Okuse, 2007). 
 
Acute and chronic pain 
Acute pain is provoked by tissue damage and comprises both phasic and tonic pain, which 
persists for a variable period of time until healing takes place (Sullivan et al., 2002). Qualities 
of acute pain translation are especially related to the lateral pain system. Pain management is 
most successful when the underlying cause of acute pain is identified and treated specifically 
and definitively (AGS Panel, 1998). Inherent to the assessment of pain is the need to evaluate 
acute pain that may indicate new concurrent illness and to distinguish this from exacerbations 
of chronic pain (Pickering et al., 2006), which is defined as pain beyond the expected time of 
healing, or more then three to six months (Merskey and Bogduk, 1994). In a large computer-
assisted telephone survey, an overall prevalence of moderate to severe chronic pain was 
defined as pain 5 on a 10-point Numeric Rating Scale (1=no pain, 10=worst pain 
imaginable) and pain  duration 6 month (Breivik et al., 2006).  
An optimal therapeutic response to pain is dependent on an adequate diagnostic 
differentiation between acute and chronic pain. Chronic pain is a syndrome with multiple 
consequences for the patient, all of them potential contributors to the patient’s experience of 
pain, which require assessment and treatment to influence the optimal therapeutic outcome. 
Furthermore, chronic pain is treatable but not curable; improvement is the realistic goal, not 
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that the pain will diminish. It is often possible to improve functional ability and to reduce the 
negative influence of the consequences of pain rather than reducing the severity of 
experienced pain. NH patients and patients with dementia will usually have several different 
diagnoses and locations of acute and chronic pain, and the onset and duration of pain are 
subject to major individual differences. In these patients three central challenges have to be 
added regarding the differentiation between acute and chronic pain: 
1. Reduced ability to remember. Due to impaired memory and verbal capacity, these patients 
have a reduced ability to remember their own previous pain experiences and relate them to 
the actual pain experience and history. They are more or less unable to contribute 
important information about the development of pain, pain intensity, location and the 
duration of acute or chronic pain.  
2. Reduced learning ability. In the chronic pain concept, a central focus is on the influence 
over time of pain on the body, mind and behaviour, often resulting in ‘learned pain 
behaviour’. Patients with cognitive failure often lack this learning ability, and the 
consequences of chronic pain differ from those for patients without cognitive failure.   
3. Difficulties in discriminating between acute and chronic pain. In patients with dementia, 
standardised mobilisation of the joints makes chronic pain visible by nociceptor 
stimulation or provocation of musculoskeletal pain. However, it is a question of 
interpretation and definition whether pain provoked by mobilisation can be defined as 
chronic or acute pain, or as ‘an acute episode of chronic pain’. 
 
The impact of dementia on the pain system 
A review of the neurological effects of AD, VaD, and FTD on the medial and lateral pain 
system concluded that the patient’s pain experience may be influenced by the origin of 
dementia diseases (Scherder et al., 2005). Atrophy and white-matter lesions are 
neuropathological features common to the dementia subtypes, and the varying degree to 
which they occur and affect the different areas of the medial and lateral pain systems 
determines the pattern of changes in pain processing. 
It has been concluded that pain tolerance is significantly higher in patients with AD than in 
non-demented individuals (Benedetti et al., 1999). It was suggested that brain lesions 
associated with AD involve the medial pain system, affecting the cognitive-evaluative, the 
motivational-affective, the memory and the autonomic responses. Patients with severe AD 
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may not reflect, expect or remember pain experiences, and they may react in a different way 
compared with mentally healthy controls. It was hypothesised that AD leads to a decreased 
experience of pain (Scherder et al., 2003a). A reduced placebo-related component in AD may 
even lead to a potentially reduced effect of analgesic treatment, because patients do not expect 
pain relief from medication. Thus, an increased need was demonstrated for analgesic drugs to 
compensate for the loss of the placebo mechanisms (Benedetti et al., 2006). 
In contrast to AD, patients with VaD or who have suffered a stroke may experience 
deafferentiation pain from white-matter lesions. The risk of complex regional pain syndromes 
or post-stroke pain is increased, including paresis of the shoulder girdle, visual deficits and 
somatosensory deficits (Baron, 2006). 
 
Diagnosis of pain in dementia by fMRI 
Analysis by functional magnetic resonance imaging (fMRI) can be used to demonstrate brain 
responses to standardised external acute pain stimuli, visualised by local cerebral blood flow 
changes and variations in deoxyhemoglobin content (Rosen et al., 1998; Peyron et al., 2000). 
In contrast to acute pain stimulation, patients with chronic pain show decreased resting 
cerebral blood flow in defined brain areas, which may be reverted by analgesic procedures 
(Peyron et al., 2000).  
Until now, only one study has focused on pain diagnostics in dementia using fMRI (Cole et 
al., 2006). In contrast to the prevailing hypothesis that AD reduces emotional responses to 
pain, this study concluded that the activity in the medial and lateral pain pathways is 
preserved in AD patients. In fact, compared with mentally healthy controls, patients with 
dementia showed greater amplitude and duration of pain-related activity in sensory, affective 
and cognitive processing regions, consistent with sustained attention to the noxious stimulus. 
The results of this study show that pain perception and processing may not be diminished in 
AD, thereby raising concerns about the current inadequate treatment of pain in this highly 
dependent and vulnerable patient group (Cole et al., 2006). This is a key question, since, if 
pain experience is not reduced in AD, the reduced prescription of pain medication (Morrison 
and Siu, 2000; Frampton, 2003; Nygaard et al., 2003; Nygaard and Jarland, 2005; Hutt et al., 
2006) would mean that pain is substantially undertreated in this frail population. 
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The prevalence of pain in nursing home patients 
Advancing age is associated with increased prevalence of pain (Ferrell et al., 1990; AGS 
Panel, 1998; Teno et al., 2004), often caused by musculoskeletal conditions, previous 
fractures and neuropathies (Feldt et al., 1998). The prevalence of pain in NHs, much of it 
undertreated, has been documented as ranging from 45% to 83% (Ferrell et al., 1990; Fries et 
al., 2001; Engle et al., 2001; Stein, 2001; Horgas and Elliott, 2004). About 94% of elderly 
people suffering from pain were expected to experience chronic pain (Miro et al., 2007). 
Persistent pain is associated with a significant limitation of daily activities, poorer self-rated 
health and increased prevalence of anxiety (Gureje et al., 2001). Poor pain assessment and 
pain management have been found to affect the overall quality of life (Frondini et al., 2007; 
Hadjistavropoulos et al., 2007), sleep (Vitiello and Borson, 2001; Rainfray et al., 2003; 
Hellstrom et al., 2004), nutrition (Black et al., 2006), mood (Reid et al., 2003), depression 
(Snow et al., 2005a; Snow et al., 2005b), healing (Jacquot et al., 1999), the risk of falls 
(Gostynski, 1991; Cumming et al., 2000), and, in particular, day-to-day functioning (Leveille 
et al., 2001; Jones et al., 2004). 
Until now, no objective biological markers of pain have been identified. However, the 
evidence for and intensity of pain is based on the patient’s description and self-reporting 
(Turk and Okifuji, 1999). Patients’ reports of pain only seem to increase up to the seventh 
decade of life, despite the increase in pain-associated diseases in old age (Helme and Gibson, 
2001). Many elderly living at home or in a NH experience both dementia and pain. The 
problem of under-diagnosed and untreated pain would therefore appear to be a challenge due 
to reduced self-reporting capacity (Ferrell et al., 1990; AGS Panel, 1998; Weiner et al., 1999a; 
Weiner et al., 1999b; Cohen-Mansfield, 2002; Frampton, 2003; Weiner, 2004). Moreover, 
patients with severe dementia are often excluded from pain studies, and, in studies that 
include patients with dementia, the frequency of pain differs substantially in patients with 
different levels of dementia (Gagliese and Melzack, 1997; Helme and Gibson, 2001).  
 
Pain in the musculoskeletal system 
Chronic musculoskeletal pain affects over 100 million people in Europe (Woolf et al., 2004). 
In older people, chronic pain is often experienced in major joints, the back, legs and feet, and 
it is reported more often than visceral pain and headaches (Helme and Gibson, 2001). In a 
cross sectional survey of an older rural community in Italy, about one third of the population 
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was affected by symptomatic peripheral osteoarthritis in knees, hands, and hips, strongly 
associated with disabilities (Mannoni et al., 2003). About 71% of the veterans in a primary 
care clinic in New York described pain with multiple localisations, also in coexistence with 
psychological and social problems (Crosby et al., 2006). Chronic musculoskeletal pain is by 
far the most common limiting factor on the activities of the ageing population, with an 
associated risk of reduced mobility, disability, muscle weakness and related impact on quality 
of life (Woolf et al., 2004). Other studies have shown that musculoskeletal pain caused by 
osteoarthritis is associated with decreased balance, week knee strength (Jadelis et al., 2001) 
and risk of falls (Leveille et al., 2002). 
 
Pain in internal organs, the head and skin 
There is increasing evidence that ageing substantially affects the way various illnesses may 
present, painful processes due to internal pathology in particular. Elderly patients with 
visceral pain conditions are far more likely than younger adults to present atypically, and 
often with diminished intensity (Helme and Gibson, 2001). Silent ischemia and painless 
myocardial infarct caused by arteriosclerosis become more frequent with advancing age, so 
that clinicians should continuously suspect and focus on these diagnoses (Stern, 2003; Stern, 
2005). Peptic ulcers, intestinal obstruction and peritonitis are other visceral conditions, often 
with reduced or absent abdominal complaints (Helme and Gibson, 2001). About 45% of older 
persons with appendicitis do not have lower-right quadrant pain as a presenting symptom, 
compared with 5% of younger adults (Wroblewski and Mikulowski, 1991). Headaches are 
commonly (70%) reported in elderly people (Gunzelmann et al., 2002), but we are not aware 
of studies addressing chronic headaches in patients with dementia. Living in a NH, 53% of 
patients are at risk of developing a pressure ulcer (Horn et al., 2002), and skin diseases found 
in 95% of the patients were described as one of the most prevalent health problems (Black et 
al., 2006). Pain in connection with genito-urinary infections is quite often described (Leoni et 
al., 2004). Catheter-associated urinary tract infection is the most common nosocomial 
infection, accounting for more than one million cases every year in American hospitals and 
NHs (Tambyah and Maki, 2000). Interestingly, none of the studies discusses this important 
issue in relation to NH patients with dementia. 
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Lack of pain treatment in patients with dementia 
Although pain is a frequent complaint in the NH, one quarter of NH patients reporting daily 
pain receive no analgesic medication (Ferrell et al., 1990; Ferrell, 1991; Sengstaken and King, 
1993; AGS Panel, 1998; Weiner and Hanlon, 2001; Ferrell et al., 2002; Won et al., 2003; 
Feldt, 2004; Gibson, 2006). The prescription and administration of analgesics in the NH, 
occur at rates lower than recommended (Horgas and Tsai, 1998; Nygaard et al., 2003; 
Nygaard and Jarland, 2005; Hutt et al., 2006; Cornali et al., 2006; Hwang et al., 2006; Jervis 
et al., 2007). Demented patients receive fewer analgesic drugs than mentally healthy controls, 
possibly due to older patients being at increased risk of drug-drug interactions as a result of  
ageing, concurrent co-morbidities and poly-pharmacy (Lindley et al., 1992). Although opioids 
remain a mainstay in pain treatment associated with surgical procedures, the use of opioid 
analgesics in elderly people is considered to be associated with adverse drug events, increased 
length of stay and hospitalisation costs (Oderda et al., 2007). Significant associations between 
the use of NSAIDs, central nervous system category medications and falls in elderly patients 
have been demonstrated (Walker et al., 2005; French et al., 2006).  
 
PAIN ASSESSMENT 
Pain assessment scales in non-demented persons 
Pain assessment is the central prerequisite for adequate pain treatment (Turk and Okifuji, 
1999). How a physician thinks about pain affects the way in which he or she assesses a patient 
who presents with pain. Because of their inherent subjectivity, pain, suffering and disability 
are difficult to prove, disprove or quantify. Disease or tissue injury is only one factor that 
contributes to the experience of pain. 
The most exact and trustworthy verification of the assessment of pain is the patient’s self-
reporting, which depends on the patient’s memory, verbal capacity, expectations and 
emotions. Good correspondence has been found between self-reports, disease characteristics, 
physicians’ or physiotherapists’ ratings of functional abilities and objective functional 
performance (Deyo and Diehl, 1983; Jette, 1987). One way of assessing pain in mentally 
intact people is to have patients’ write diaries about their activities (Maunsell et al., 2000; 
Chambers et al., 2003). The three most commonly used methods of assessing changes in pain 
intensity and benefit of treatment interventions are the Verbal Rating Scale (VRS) (Seymour 
et al., 1985), the Visual Analogue Scale (VAS) (Jensen et al., 1986) and the Numerical Rating 
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Scale (NRS) (Kremer et al., 1981). The McGill Pain Questionnaire includes a descriptive 
scale of pain intensity, a human figure to mark locations of pain and adjectives from 20 
categories reflecting sensory, affective, and evaluative components (Melzack, 1975; Melzack, 
2005). Less common measures include various versions of a picture or face scale, and the 
Descriptor Differential Scale of Pain Intensity (DDS-I) (Jensen and Karoly, 2001). For such 
pain assessment tools to be used, it is a requirement that the patient is mentally healthy and 
oriented with respect to time, place and his or her own person. 
 
Proxy rater 
In addition to seeking information directly from a patient, information can be obtained from a 
number of other (proxy) sources. A proxy is defined as a person or agency of substitute 
recognised by law to act for, and in the best interests of the patient (Grootendorst et al., 1997; 
Hughes and Preski, 1997). In the context of assessment, the term proxy is used more widely to 
refer to an informant who has knowledge of the circumstances or condition of the patient (e.g. 
a caregiver or spouse). This can be helpful in patients with communication difficulties 
because a proxy will spend much more time with the patient than the physician, and will have 
opportunities to observe the patient’s behaviour over time. Knowing the patient and his pain 
history may be a prerequisite for valid pain assessment by a proxy (Morello et al., 2007). 
However, this knowledge will always be subjective, depending on how long and how well a 
proxy rater has known or knows the patient and on the proxy’s own pain experience and skills 
in pain assessment. Little is known about the validity and reliability of proxy pain reports for 
patients with dementia, but agreement between patient and proxy reports regarding pain 
assessment underlines that nurses’ perceptions and observations may be an important source 
(Fisher et al., 2002; Boyer et al., 2004).  
 
Behavioural pain assessment scales  
Self-report pain scales cannot be used when dementia increases in severity (Closs et al., 
2004). Although research evidence suggests that elderly people with mild to moderate 
dementia can provide valid pain reports, it is unclear at what level of impairment the validity 
of self-reports becomes questionable (Feldt et al., 1998; Hadjistavropoulos and Craig, 2002; 
Closs et al., 2004). Uncertain results may lead to the interpretation that they have less pain 
complaints than non-demented elderly (Parmelee, 1996; Proctor and Hirdes, 2001). 
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In dementia, the assessment of pain depends on the ability of health personnel to register and 
interpret verbal and non-verbal expressions of pain (Prkachin et al., 1994). Each individual 
episode of pain is complex. The estimate of pain depends on the relationship between the 
patients’ verbal expressions of pain and pain behaviour and the observer’s interpretation. 
Although it is not considered sufficient to rely solely on pain behaviour indicators, such 
indicators should be assessed in individuals with dementia. External signs have to be observed 
and interpreted by an external rater, who extrapolates the meaning of behaviour that might be 
caused by pain (Snow et al., 2004a). However, little is known about the relationship between 
pain behaviour and the interpretation of overall pain intensity in dementia. 
In response to a strong need to assess pain and improve pain management in patients with 
cognitive impairment, several staff-administered pain behavioural observation scales have 
been developed (Hurley et al., 1992; Simons and Malabar, 1995; Baker et al., 1996; Ferrell et 
al., 2000; Feldt, 2000; Kovach et al., 2001; Lefebvre-Chapiro, 2001; Fisher et al., 2002; 
Villanueva, 2003; Warden et al., 2003; Fuchs-Lacelle and Hadjistavropoulos, 2004; Abbey, 
2004; Davies et al., 2004; Snow et al., 2004b; Defrin et al., 2006; Stevenson et al., 2006; 
Lautenbacher et al., 2007; Morello et al., 2007). Most of these scales have been reviewed, 
some with promising results (Herr et al., 1998; Stolee et al., 2005; Zwakhalen et al., 2006a). 
Since 1992, more than 20 pain assessment instruments have been developed to register acute 
and chronic pain indirectly in older persons with dementia (Table 1). These instruments are 
based on observations by a rater who assesses the patients’ behaviour and functioning, 
including facial and or body language, and other aspects such as sleep, appetite, daily 
activities and social indicators. However, the interpretation of pain behaviour is challenging. 
There is strong evidence that pain behaviour indicators such as guarding, bracing or 
grimacing are relevant (Hadjistavropoulos et al., 2000a; Keefe et al., 2001), but these 
indicators may be absent or difficult to interpret, because symptoms attributed to dementia 
may also be indications of pain (Herr, 2002). Furthermore, behavioural indicators are more 
likely to be associated with acute pain, which is less prevalent than persistent pain in older 
adults (Gibson, 2006). Distinguishing pain behaviour from psychological distress such as fear, 
depression, or restlessness caused by dementia is a prerequisite for valid pain assessment.  
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Short observational scales 
Clinically relevant measures can be categorised into those that are short (comprising 10 items 
or less) and those that are extended (comprising more than 10 items). Table 1 includes 10 
short measures of 10 or less items such as the Discomfort Scale (DS-DAT) (Hurley et al., 
1992), Checklist of Nonverbal Pain Indicators (CNPI) (Feldt, 2000), Assessment of 
Discomfort in Dementia (ADD) (Kovach et al., 2001), Doloplus-2 (Lefebvre-Chapiro, 2001), 
the pain report of the Mini Data Set (MDS) (Fisher et al., 2002), Pain Assessment in 
Advanced Dementia (PAINAD) (Warden et al., 2003), the Proxy Pain Questionnaire (PPQ) 
(Fischer et al., 2003), Abbey Scale (Abbey, 2004), modification of the Facial Action Codin 
System (FACS) (Lautenbacher et al., 2007) and the measurement of pain in non-verbally 
communicating patients (ECPA) (Morello et al., 2007). These scales differ with respect to the 
use of proxy raters such as a collaborative informant, who is familiar with the patient, or an 
observer, who is unfamiliar with the patient. When a proxy rater knows the patient, he may be 
better able to judge changes in behaviour, appetite, restlessness, isolation or sleep. Knowledge 
of the patient is required by the DOLOPLUS-2, Abbey Scale and ECPA. A rater who does not 
need to know the patient can complete the remaining scales.  
 
Extended observational scales 
Lengthy scales (between 15 and 60 items) include more behaviour indicators or psychosocial 
observations are also shown in Table 1, through the Observational Behavior Tool (Simons 
and Malabar, 1995b),  the Behavioral Checklist (Baker et al., 1996), Geriatric Pain Measure 
(GPM) (Ferrell et al., 2000), Pain Assessment in Dementing Elderly Scale (PADE) 
(Villanueva, 2003), Non-communicative Patients Pain Assessment Instrument (NOPPAIN) 
(Snow et al., 2004b), Pain Assessment Checklist for Seniors with Limited Ability to 
Communicate (PACSLAC) (Fuchs-Lacelle and Hadjistavropoulos, 2004), the Pain 
Assessment Tool for Use with Cognitive Impaired Adults (Davies et al., 2004), the 
Discomfort Behavior Scale (DBS) (Stevenson et al., 2006)  and the Non-Communicative Pain 
Checklist (NCCPC-R) (Defrin et al., 2006). Extended scales support the potential of the tool, 
because they may be likely to encompass the varied responses of patients who suffer very 
diverse effects of brain pathology (Hadjistavropoulos et al., 2007). Some items of the 
PACSLAC require an informant, while in the case of the other scales, the rater may be 
unfamiliar with the patient.  
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Psychometric property testing of behavioural pain scales for patients with dementia has not 
been  completed for all measures. Internal consistency is reported for the Abbey Scale (0.74-
0.81), CNPI (0.54-0.64), DS-DAT (0.86-0.89), DOLOPLUS-2 (0.82), PAINAD (0.50-0.67), 
PADE (0.24-0.88), and PACSLAC (0.85). Unsatisfactory and unreported internal consistency 
increases the risk that not all items assess the same construct, i.e. pain. In a process of item 
reduction and translation of the PASCLAC into Dutch, the PACSLAC-D retained 24 of 60 
items, including the observations that the patient may be irritable, upset, restless or sad 
looking (Zwakhalen et al., 2007). These behaviours are also typical of and frequent in 
psychiatric disturbances related to dementia, as the prevalence of behavioural disturbances 
ranges between 60% and 80% in NHs (Cipher et al., 2006). 
It is easier to achieve good internal consistency in scales with more than 10 items (Pallant, 
2005). Very short scales like the MDS, PPQ, and PAINAD may, therefore, produce 
questionable information. Moreover, the PAINAD includes respiratory items, which, while of 
importance, may not be typical of pain expression. Other short scales like the DOLOPLUS-2, 
DS-DAT, and Abbey demonstrated satisfactory results. However, the DS-DAT provided 
validity information involving fever as a gold standard illness, which is not comparable with 
pain. The observation of pain behaviour during everyday activities or body movements is 
performed using DOLOPLUS-2, NOPPAIN, PACSLAC and ECPA. These movements are 
spontaneous, and not standardised and guided.   
 
Pain components 
As demonstrated in Table 2, pain scales include different components of the pain process. The 
motivational-affective pain component (A) expressed by pain behaviour such as facial 
expression, pain noises and/or defence is included in most of the scales. The sensory-
discriminative pain component (S), such as pain location, pain intensity and pain duration, is 
presented in scales like the GPM and ADD. None of the tools registers all these three 
components. One instrument includes a question about pain duration (acute or chronic pain) 
(Abbey, 2004). While of importance, memory disturbances and different pain localisations 
with different onsets of pain make the registration of pain duration challenging. Furthermore, 
it is difficult to differentiate between acute and chronic pain behaviour, although such 
knowledge has serious consequences for pain treatment.  
 
 
Table 1. Characteristics of clinically relevant observational pain behaviour scales for persons with dementia  
 
 
 
    Pain components                                Pain characteristics Pain scores 
             Location Intensity             Duration Range Sum Overall Instrument Number 
of items S A C Au  MS  IO  Acute  Chronic    
DS-DAT (Hurley et al., 1992)  9  x      x    x  
Observational Behavior Tool 
    (Simons and Malabar, 1995) 
25  x  x          
Behavioral checklist  
(Baker et al., 1996) 
20  x            
GPM (Ferrell et al., 2000)  x         x  x  
CNPI (Feldt, 2000)  6  x    x   x   x  
ADD (Kovach et al., 2001) 10 x   x   x       
Doloplus-2 (Lefebvre-Chapiro, 2001) 10  x    x     0-30 x  
MDS (Fisher et al., 2002)  3   x     x    x  
PADE (Villanueva, 2003) 24  x    x  x      
PAINAD (Warden et al., 2003)  5  x         0-10 x  
PPQ (Fischer et al., 2003)  3        x   0-10  x 
Abbey Scale (Abbey, 2004)  6  x  x   x  x x 0-18 x  
NOPPAIN (Snow et al., 2004b) 15  x x   x  x     x 
PACSLAC (Fuchs-Lacelle and 
    Hadjistavropoulos, 2004) 
60  x  x  x     0-60 x  
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Pain Assessment for Use in Cognitive     
   Impaired People  (Davies et al., 2004) 
16  x  x  x        
DBS (Stevenson et al., 2006) 17  x          x  
NCCPC-R (Defrin et al., 2006) 27  x  x     x  0-81 x  
FACS (Lautenbacher et al., 2007) 10  x      x x     
ECPA (Morello et al., 2007)  8  x    x    x 0-32 x  
 
______________________________________________________________________________________________________________________________ 
S: sensory-discriminative, A: motivational-affective, C: cognitive-evaluative, Au: autonomic-neuroendocrine; MS: pain from the musculoskeletal system;   
IO: pain from internal organs, the head and skin; DS-DAT: Discomfort Scale, GPM: Geriatric Pain Measure, CNPI: Checklist of Nonverbal Pain Indicators, 
ADD: Assessment of Discomfort in Dementia, MDS: pain report of the Mini Data Set, PADE: Pain Assessment in Dementing Elderly Scale,               
PAINAD: Pain Assessment in Advanced Dementia, PPQ: Proxy Pain Questionnaire, NOPPAIN: Non-communicative Patient’s Pain Assessment Instrument, 
PACSLAC: Pain Assessment Checklist for Seniors with Limited Ability to Communicate, DBS: Discomfort Behavior Scale, NCCPC-R: Non-Communicative 
Pain Checklist, FACS: modification of the Facial Action Codin System, ECPA: measurement of pain in non-verbally communicating patients.    
_____________________________________________________________________________________________________________________________
The cognitive-evaluative (C) pain component is included in the MDS and NOPPAIN, which 
ask the patient about his pain (‘Do you have pain?’). In severe dementia, this item may be 
questionable, possibly leading to misinterpretation by staff if the patient does not understand 
the question. Autonomic-neuroendocrine (Au) pain reactions are included in the 
Observational Behavior Tool, ADD, Abbey, Pain Assessment Tool for Use with Cognitive 
Impaired Adults, PASCLAC, and NCCPC-R. These items may be questionable in elderly 
patients with chronic pain. Autonomic measures seem to be of little relevance in pain 
syndromes of a musculoskeletal nature (Flor, 2001), while they play a major role in vascular 
pain problems (migraine headaches, Reynaud’s disease), in pain syndromes related to 
sympathetic dysfunction (complex regional pain syndromes) and in laboratory investigations 
that include acute pain stimuli. Measurements of the heart rate, skin temperature or blood 
pressure will be influenced by changes in the skin, multi-morbidity of the patients and drug 
consumption. 
 
Table 2. Different components of the pain process  
Pain components Examples of items 
Motivational-affective                  (A) • Pain noises: ‘Ow, that hurts’, moaning, 
groaning, mumbling  
• Facial expression: tighten face, change in 
eyes, frowning, creasing forehead, grimacing 
• Defensive behaviour: Body language such as 
pulling away, freezing, stiffening 
Sensory-discriminative                  (S) Pain location, intensity, duration  
Cognitive-evaluative                     (C) Memory, reflection, expectation 
Autonomic-neuroendocrine          (Au) Blood pressure, pulse, sweat, red face 
 
 
Pain intensity scores 
Scoring procedures for an assessment tool may not be straightforward. To get an overall 
impression of pain intensity, mean or sum scores for pain behaviour are usually calculated. 
The addition of these observations may not necessarily be equivalent to pain intensity, as 
several behaviours are typical for pain as well as dementia. It is a prerequisite that the items 
used represent the same phenomenon, pain. If pain behaviour signalises pain, one key 
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question is how pain behaviour can be inferred to a valid and reliable pain intensity score. 
The pain assessment tool should also be useful for, for example, patients with Parkinson’s 
disease, contractures, paresis and aphasia, whose ability to express pain behaviour will be 
substantially reduced. The interpretation of observed pain behaviour in patients who are no 
longer able to express such behaviour has to be guarantied by an overall pain intensity 
scoring system and not by sum scoring of individual pain behaviours. This is required by 
NOPPAIN, in which the rater has to estimate the overall pain at the end of the measure. The 
other pain scales use a sum score system for pain behaviour. 
 
Why a new pain assessment scale? 
Researchers tend to dismiss existing scales and develop new instruments, which is easier 
than establishing good reliability and validity for already existing ones (Streiner and 
Norman, 2006). Reviews of pain assessment tools for patients with dementia conclude that 
there are promising instruments in development. These studies also underline that there is 
insufficient evidence of reliability and validity testing, and they do not recommend any one 
tool for use in all populations and settings at present (Herr et al., 2006; Hadjistavropoulos et 
al., 2007). When starting our project, we were not convinced of the necessity of developing a 
new instrument, as approximately 20 scales had already been developed in this context. 
Instead, our aim was to translate NOPPAIN (Snow et al., 2004b) into Norwegian and to test 
the tool with respect to psychometric properties. However, the lack of registration of pain in 
internal organs, the head and skin, and inconsistency in the scoring system were considered 
to be unsatisfactory.  
A new pain assessment tool was developed to address shortcomings in existing scales and to 
take at least three substantial new aspects into consideration:  
1. Movement-related pain behaviour seems to be of clinical significance (Mercadante and 
Arcuri, 2006), but few attempts have been made to investigate the utility of using a 
standardised movement protocol (Gibson, 2006). A shortcoming of existing scales is that 
pain behaviour in connection with movements is only observed in everyday activities as they 
occur naturally (Feldt, 2000; Lefebvre-Chapiro, 2001; Villanueva, 2003; Snow et al., 2004b; 
Fuchs-Lacelle and Hadjistavropoulos, 2004; Davies et al., 2004).  However, pain tends to 
change the way activities are performed (Magnussen et al., 2004). Changes may be subtle 
and not easily observed during everyday activities, as people may simply move less, or 
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change the way they move in order to avoid pain (Lethem et al., 1983; Vlaeyen and Linton, 
2000; Hasenbring et al., 2001). To better reveal pain behaviour related to the 
musculoskeletal system, a protocol of standardised active, guided movements of all body 
parts was included in the MOBID and the MOBID-2 Pain Scale. 
2. Pain from internal organs, the head and skin gives rise to frequent complaints in elderly 
persons, but may be difficult to diagnose because it is often widespread, diffuse and poorly 
described (Giamberardino, 2005). In dementia, the assessment of such painful conditions 
may be even more challenging, and prevalence data are incomplete. So far, none of the 
existing pain tools systematically registers behaviour that might be related to pain from 
internal organs, the head and skin. We considered primary caregivers to be key persons in 
the observation of such behaviour, as they are familiar with the patient and his usual 
behaviour. The design of the two-parted MOBID-2 Pain Scale is in line with 
Hadjistavropoulos et al. (2007), who argued that pain from the musculoskeletal system often 
coexists with other co-morbid conditions, implying that disease-modifying therapies are 
needed to diminish pain. 
3. In the MOBID and MOBID-2 Pain Scale, primary caregivers are encouraged to interpret 
each test item and the overall pain independently and to judge whether their observations are 
related to pain or to behavioural disturbances due to dementia. Usually, observational pain 
tools estimate total pain intensity by summing scores for separate pain behaviours. Such 
scoring procedures may be uncertain, as patients with dementia may not present pain 
behaviour at all, or use less obvious indicators such as agitation or aggression. This is one of 
the key problems, since the prevalence of behavioural disturbances is high in dementia 
(Cipher 2006).  
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AIMS OF THE STUDY 
The overall aims of this study were:  
Paper I. To describe the development of the nurse-administered Mobilization-Observation-
Behaviour-Intensity-Dementia (MOBID) Pain Scale for older persons with dementia. To 
investigate the reliability and validity of the scale, including the key question of whether the 
presence of pain, pain behaviour indicators and pain intensity in patients with dementia can 
be assessed by MOBID. 
Paper II. To examine the extended intra-rater and inter-rater reliability of the MOBID Pain 
Scale by external raters, using video recordings. In particular, we wanted to focus on the 
reliability of pain behaviour indicators and pain intensity scores for individual items, and the 
overall pain scores.   
Paper III. To develop and test the extended instrument, the Mobilization-Observation- 
Behaviour-Intensity-Dementia (MOBID-2) Pain Scale, in order to also assess behaviour that 
might be caused by pain from internal organs, the head and skin. In particular, we wanted to 
focus on the validity of MOBID-2, comparing test scores with the physicians’ pain 
examination of the patient and other types of pain indicators. 
Paper IV. To explore pain among NH patients with different levels of dementia and 
dementia type (AD, VaD, and ADVaD), and to explore the relationship between the 
MOBID-2 pain intensity scores and the use of pain medication assessed in the clinical setting 
of a cross-sectional study. 
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METHODS AND PARTICIPANTS 
INSTRUMENT DEVELOPMENT 
Focus group interview 
The MOBID and the MOBID-2 Pain Scales were developed by focus group interview, 
including an expert panel experienced in the treatment and care of elderly persons with 
dementia, and/or experienced in the examination of psychometric properties of pain 
assessment tools: one registered nurse (RN), one licensed practical nurse (LPN), two 
physicians, and two physiotherapists. A focus group interview is a discussion among a small 
group of informants (six to twelve people), in which they talk freely and spontaneously 
about themes considered important to the investigation under the guidance of a facilitator 
(Streiner and Norman, 2006). Normally, the persons of interest would be included in this 
interview, but this was not possible with demented patients. 
  
Devising the items  
In Paper I, the MOBID Pain Scale was developed to capture pain related to the 
musculoskeletal system during standardised active, guided movements in patients with 
dementia. A process of item generation and subsequent reduction was applied, and reliability 
and validity were tested in a clinical setting and also using video recordings. Five active 
movement items were retained. The tester was to guide the patient to (1) open both hands, 
(2) stretch both arms towards the head, (3) stretch and bend ankles, knees and hips, (4) turn 
over in bed to both sides and (5) sit at the bedside. One observation item consisting of the 
patient lying in bed, and one item consisting of brushing teeth/mouth care were removed 
from the scale because of lower Cronbach’s alpha  coefficient. 
Based on our own clinical experience and a survey of the literature (Hurley et al., 1992; 
Ekman, 1993; Simons and Malabar, 1995; AGS Panel, 1998; Hadjistavropoulos et al., 
2000b; Craig et al., 2001; Villanueva, 2003; Warden et al., 2003; Fuchs-Lacelle and 
Hadjistavropoulos, 2004; Abbey, 2004; Snow et al., 2004b; Defrin et al., 2006; Herr et al., 
2006), three key indicators of pain behaviour were selected, accompanied by explanatory 
words: ‘Pain noises’ (‘That hurts!’, groaning, moaning, gasping, screaming), ‘Facial 
expression’ (grimacing, frowning, tightening mouth and closing eyes), ‘Defence’ (freezing, 
guarding, pushing and crouching). These aspects of pain behaviour have usually been 
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included in staff-administered instruments (Stolee et al., 2005). In MOBID, nurses were 
encouraged to pay attention to the patient’s pain behaviour, observe the patient before 
starting mobilisation, clearly explain what was going to happen, mobilise the patient gently 
through the activities and reverse the movement immediately if pain behaviour was 
perceived. Observations were rated after each activity by ticking the boxes for ‘Pain noises’, 
‘Facial expression’ and ‘Defence’, and inferring the observation into pain intensity by 
putting a cross on the line for the 0-10 point Numerical Rating Scale (NRS) (Jensen et al., 
1999), answering the question: ‘How intense do you regard the pain to be?’ 
In the extended MOBID-2 Pain Scale, discussed in Paper III, MOBID is renamed as 
MOBID-2 Part 1. In MOBID-2 Part 2, the nurse was encouraged to assess behaviour 
presenting other types of pain that might originate from the (6) head, mouth and neck, (7) 
heart, lung and chest wall, (8) the abdomen, (9) the pelvis and/or genital organs and (10) the 
skin. Pain behaviour was to be monitored retrospectively over time (today, or during the last 
few days up to one week), and it could be caused by a disease, wound, infection and/or 
injury. To increase the nurse’s awareness, a pain drawing (front and back) of a human body 
was included in order to register the possible pain locations. The caregiver was encouraged 
to put one or more crosses on this pain drawing, indicating the observed pain behaviour 
(Pain noises, Facial expression and Defence), and to infer pain intensity by putting a cross on 
the line for the 0-10 point Numerical Rating Scale (NRS). Finally, after scoring the 10 
separate items, an independent overall pain intensity score was reported, again using the 
NRS. 
If overall pain was judged to be above three on the NRS (Jensen and Karoly, 2001), the test 
result was to be reported to the physician responsible for the patient, with a view to 
providing appropriate treatment and care. 
 
Nursing home patients 
The Bergen Red Cross NH is one of the largest NHs in Norway, including units for long-
term care, rehabilitation, specialised dementia care and palliative care. Inclusion criteria for 
the study were: age>65 years, and a regular family visitor or legal guardian; exclusion 
criteria were delirium, psychosis, and/or short stay admission (4 weeks). In Papers I and 
II, 26 patients with severe dementia and chronic pain (>3 months) (Merskey H, 1986; 
Merskey H et al., 1994) were included. In Paper III, 77 patients with severe dementia with 
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or without pain met the criteria for participation. In Paper IV, 181 consecutive, long-stay 
NH patients at different stages of dementia and with different dementia diagnoses were 
included. 
 
Nursing home staff 
Two separate groups of the MOBID Pain Scale raters participated in Papers I and II. The 
first group consisted of the patients’ primary caregivers (N=11), who were familiar with the 
patients’ habits and regular behaviour. The second group consisted of external raters A, B, 
and C (N=3), who did not know the patients. In Paper III, each patient was assessed by a set 
of two nurses (N1 and N2), who were familiar with the patients’ habits and had had 
responsibility for the patient during the last four weeks. Altogether, 14 sets of nurses (N=28) 
participated in the testing of the 77 patients. In Paper IV, primary caregivers (N=43), who 
were familiar with the patients’ habits tested the patients using MOBID-2. Before data 
collection, the raters received a standardised briefing in which they were given basic 
information about dementia, pain physiology, pain behaviour and pain assessment. They 
practised the use of the MOBID or MOBID-2 Pain Scale in at least three patients. In Papers 
I and III, two physicians from the NH participated, and four physicians in Paper IV. 
 
Examination 
In Papers I-IV, demographic information about the participants was taken from the patients’ 
medical charts. Together with the primary caregivers, a geriatric study nurse rated each 
patient’s cognitive function using the MMSE (Folstein et al., 1975), severity of dementia 
using the Clinical Dementia Rating (CDR) (Hughes et al., 1982) and Severe Impairment 
Rating Scale (SIRS) (Rabins and Steele, 1996). Measurements of psychiatric and 
behavioural changes included the Cornell Scale for Depression in Dementia (Alexopoulos et 
al., 1988), Neuropsychiatric Inventory (NPI) (Cummings et al., 1994), as well as the 
Activities of Daily Living scale (ADL) (Mahoney and Barthel, 1965, Sheikh et al., 1979, 
Laake et al., 1995). The physicians responsible for diagnostics and treatment collected the 
data about medical conditions (ICD-10), dementia type and pain variables. This included 
information about pain diagnoses, pain locations, pain treatment (World Health 
Organisation, 1996) and pain intensity obtained using the NRS  (Jensen and Karoly, 2001). 
In Paper IV, dementia was also diagnosed according to the international classification of 
diseases (ICD-10) (World Health Organisation, 1993), Diagnostic and Statistical Manual of 
  
26 
Mental Disorders (American Psychiatric Association, 1994) based on history, physical and 
mental examination, routine laboratory tests and cerebral Computer Tomography (cCT) of 
the head (71% of the patients). 
 
Video recordings 
When the patients were guided through the MOBID procedure in Paper I, the patients’ 
behaviour during the standardised movements was recorded by continuous video recording 
(MOBID-v) using a stationary camera (at a distance of 3.80 metres) and a mobile camera. 
Voices and noises made by patient and staff were documented using a sensitive microphone. 
The operator processed the video recordings (N=26) using a visual dictionary (Ekman and 
Friesen, 1969) for film frame, motion time and noises. In the final presentation, each 
MOBID item was announced by a short title. The film sequence for each patient lasted six to 
eight minutes, resulting in three hours of film material, which formed part of the database in 
Papers I and II.  
         
Test procedures 
In Paper I, the patients’ primary caregivers observed two to three patients each during 
regular morning care and rated overall pain intensity using an NRS after care. Shortly 
afterwards, the patients were assessed by their caregivers using the MOBID procedure at the 
bedside (MOBID-b), which was also recorded in video recordings (MOBID-v). About four 
to six days after the bedside assessment, each primary caregiver assessed her own video 
recording and repeated the scoring (MOBID-v). In addition, three external raters (A, B and 
C) assessed the 26 videos concurrently and independently. Face validity was examined by an 
expert panel.   
In Paper II, the intra and inter-rater reliability of the MOBID Pain Scale was reported by the 
raters A, B, and C on day 1, 4 and 8. They watched the videos and filled in the MOBID form 
for observed pain behaviour for each item, inferred pain intensity and overall pain intensity.  
In Paper III, the inter-rater reliability of the MOBID-2 Pain Scale was assessed by two 
groups of nurses who rated the patients concurrently and independently in a clinical setting. 
Retesting was performed the next day. The time needed to fill in MOBID-2 was recorded. 
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Two physicians collected information regarding pain variables on the same day. Face 
validity was examined by an expert panel.   
In Paper IV, 181 patients were assessed by their primary caregivers, who used the MOBID-
2 Pain Scale in a clinical setting. The time needed to fill in the MOBID-2 was recorded. Four 
physicians collected information regarding pain variables on the same day.  
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STATISTICAL ANALYSES 
Reliability 
Reliability is a prerequisite for validity (Rothstein and Echternach, 1993), and no measure 
should be used without evidence of both reliability and validity (Jensen et al., 1999). 
Reliability is the degree to which test scores are free from errors of measurement. Internal 
consistency, intra-rater, test-retest and inter-rater reliability are attributes of reliability used 
in this thesis.  
Internal consistency expressed by Cronbach's alpha (), the corrected item-total correlation 
and the term ‘ if item deleted’ were calculated for each item in MOBID and MOBID-2 in 
Papers I and III. Internal consistency refers to the degree to which the items that make up 
the scale measure the same underlying construct, and care should be taken not to include 
items that assess a different construct (Streiner and Norman, 2006). There is no standard for 
what constitutes an acceptable coefficient of internal consistency. An  in the vicinity of 
0.70 has been suggested as being sufficiently high (Polit and Beck, 2006). Cronbach’s  
formula is the most commonly used indicator of internal consistency, but it is quite sensitive 
to the number of items in the scale. For short scales (<10 items), it may be appropriate to 
report the corrected item-total correlation, which gives an indication of the degree to which 
each item correlates with the sum of all other items. The step ‘ if item deleted’ indicates the 
impact of removing the item from the scale. These values are compared with the final  
value obtained (Pallant, 2005). If any of the values are higher than the final  value, it should 
be discussed whether to remove the item from the scale. 
Intra-rater reliability is the consistency with which one rater assigns scores to a single set of 
responses on two occasions. If a rater uses video recording, as was the case in Papers I and 
II, she can observe the same pain behaviour on different dates. Because the behaviour being 
assessed is identical on both occasions, any variability in scores is, in fact, related to 
measurement errors on the part of the rater. If the function to be tested is performed 
repeatedly, as in the test-retest procedure used in Paper III, errors from the instrument, from 
the application of the instrument and also changes in the behaviour of the subject being 
tested may cause variability. It may be unreasonable to believe that individual measurements 
of chronic pain can be easily reproduced, because pain is a changing phenomenon 
(Domholdt, 2005). The test-retest reliability of a pain assessment scale is affected by intra-
subject variability, which should not be regarded as a measurement error. As performed in 
Paper III, test procedures should be chosen in which raters act consistently, in order to 
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detect any clinical changes in the patients. Thus, test-retest reliability is also an important 
step in the validation process of a new method.      
Inter-rater reliability is the consistency of scores between different raters (Paper I-III). This 
is determined when two or more raters judge the performance of one group of subjects at the 
same point in time (Domholdt, 2005). The reliability of observations can be estimated in 
different ways. When comparing paired assessments, one is concerned with the relationship 
between the two measures (relative reliability) and the magnitude of the differences between 
the two assessments (absolute reliability). The intra-class correlation coefficient (ICC) 
denotes relative reliability and measures the intra-rater and inter-rater reliability of subjective 
assessments (Ottenbacher and Tomchek, 1993). In this thesis, intra and inter-rater and test 
retest reliability for pain intensity were analysed by intra-class correlation coefficient (ICC) 
model 1,1 (Shrout and Fleiss, 1979), which is equivalent to the SPSS-model ‘one-way 
random’. 
In order to assess absolute reliability and the differences between the two measurements, the 
within-subject standard deviation (sw) was also calculated, which includes both random and 
systematic components of measurement error and is expressed in the same metric unit as the 
measurement tool (Bland and Altman, 1996).  
Additionally, in Papers I-III, the intra-rater, inter-rater and test-retest reliability of observed 
pain behaviour indicators in MOBID, MOBID-2 Part 1 were analysed by kappa () statistics, 
as were pain localisation on the pain drawing in MOBID-2 Part 2 . This test provides a 
measure of the concordance between the raters and is chance-corrected. The interpretation of 
 was: 0.20 (poor), 0.21-0.40 (fair), 0.41-0.60 (moderate), 0.61-0.80 (good), 0.81 (very 
good agreement) (Altman, 1995). 
 
Validity  
Measurement validity is the appropriateness, meaningfulness and usefulness of the specific 
inferences made on the basis of the test scores (Domholdt, 2005). There is no simple, 
absolute, direct test of validity; instead, evidence is brought to bear from a variety of sources. 
Research evidence can add to the argument for validity, but it can never directly or 
absolutely test the correctness of a construct (Rothstein and Echternach, 1993). For attributes 
such as pain, no gold standard or clear-cut indicator exists, making the validation process for 
a pain assessment scale challenging. The validation of a scale involves the collection of 
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empirical evidence concerning its use. A pain assessment scale for patients with dementia 
will be valid if it adequately measures the pain characteristic in question (e. g. intensity, 
location, duration of pain) and not behavioural disturbances relating to dementia (e. g. 
depression, restlessness, anxiety). Moreover, a scale will be valid if it reflects changes in 
pain experiences, such as after pain treatment, also expressed by the responsiveness of a 
scale. In this thesis, arguments for the face-, construct- and concurrent validity of the 
MOBID and the MOBID-2 Pain Scale were examined. 
Face validity: One issue that must be decided before the items that make up a scale are 
selected is whether or not they have face validity (Streiner and Norman, 2006), i.e. do the 
items actually measure what they superficially appear to measure? If the item appears 
irrelevant, then the respondent may omit it, irrespective of its possible excellent 
psychometric properties. To explore face validity, the MOBID (Paper I) was presented to a 
focus group consisting of two RNs, two LPNs, two physiotherapists, an occupational 
therapist and two physicians, all experienced in the evaluation and management of pain in 
NH patients. The group considered the MOBID test procedure to be a feasible means for 
nurses to identify pain behaviour related to musculoskeletal pain in connection with morning 
care. However, they suggested adding items to capture pain not necessarily provoked by 
movement, such as visceral- and neuropathic pain and headache syndromes. 
This was taken into account in the extended MOBID-2 Pain Scale, which included five items 
concerning pain from internal organs, the head and skin. As commented by the focus group, 
the judgement of a demented patient’s pain experience will always be challenging, especially 
when pain stems from the head, internal organs or skin.  It should therefore be a prerequisite 
that the rater is familiar with the patient’s usual behaviour and that pain behaviour is 
monitored over time.  
Construct validity: Construct validity involves testing a scale, not against a single criterion, 
but in terms of theoretically derived hypotheses concerning the nature of the underlying 
variable or construct (Pallant, 2005). As patients with dementia and pain tended to avoid 
painful movements and thereby concealed acute and chronic pain, MOBID included 
standardised guided movements to reveal pain in the musculoskeletal system. To explore the 
construct validity of the MOBID Pain Scale in Paper I, the following theoretical questions 
were examined using the non-parametric Wilcoxon Signed Rank Test (Pallant J, 2005): 1) Is 
overall pain intensity less captured during regular care activities than during standardised, 
guided movements using MOBID Pain Scale? 2) Are pain intensity scores for MOBID items 
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obtained in a bedside situation different from those obtained from watching the videos? 3) Is 
the ability to observe pain behaviour using the MOBID Pain Scale dependent on knowing 
the patient? Finally, Spearman Rank Order Correlation was used to examine the association 
between the maximum and mean pain intensity scores for each test item and overall pain 
intensity. The question of whether the number (0-3) of observed pain behaviour indicators is 
related to the staff’s interpretation of pain intensity was calculated by one-way between 
groups ANOVA with linear trend, comparing one independent variable (pain behaviour) 
with one dependent continuous variable (pain intensity) (Domholdt, 2005; Pallant, 2005). In 
Paper III, construct validity was examined with respect to the association between the 
overall pain intensity score and the maximum item score for MOBID-2 Part 1 and Part 2, 
calculated using Spearman’s Rank Order Correlation (rho). 
Concurrent validity: Concurrent validity is an issue when a new tool is compared with a 
measurement standard (Domholdt, 2005). The association between the overall pain intensity 
in MOBID-2 as assessed by nurses and other parameters of pain derived from physicians’ 
clinical examinations, was calculated using Spearman’s Rank Order Correlation with respect 
to the 1) number of pain diagnoses, 2) number of pain locations, 3) number of pain 
medications according to World Health Organisation’s analgesic ladder (WHO I-III), and 4) 
pain intensity scores assessed using NRS.  
In Paper IV, one-way ANOVA was used for comparisons between the groups for 
continuous variables. Pair wise between-groups comparisons were provided by post hoc tests 
(Bonferroni correction) (Field, 2006). Two-way ANOVA was used to compare pain intensity 
scores for the MOBID-2 Pain Scale as the dependent variable with levels of dementia, 
dementia diagnoses and pain medications (independent variables). For the ordered categories 
(levels of dementia and pain medication categories), linear contrast was used to examine 
trend in relation to level. Simple contrast was used to compare different types of dementia 
diagnoses, using no diagnosis as the reference category.  
The data were analysed using SPSS for Windows 13.0.  
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APPROVAL PROCESS 
In this thesis, the protocol and the consent procedure for the thesis, including video 
recording, were approved by the Regional Committee for Medical Research Ethics (REK-
Vest) and the Norwegian Data Inspectorate. The approval of the Norwegian Directorate for 
Health and Social Affairs (www.shdir.no) was a prerequisite for data collection, including 
staff being released from their duty of confidentiality.  The fact that patients with dementia 
cannot give informed consent and that they lack an understanding of the consequences of the 
research project were arguments used by the Directorate to reject approval. Furthermore, 
they argued, presumed consent by relatives is not possible, because it is not stated whether 
they are aware of patient’s interests. Finally, they argued that patients with dementia are 
vulnerable and have to be protected in connection with research, and the use of video 
recording in particular. 
In order to take account of  legal and ethical considerations, our application was improved 
with the help of a qualified lawyer, experts in ethics and colleagues, and a revised 
application was sent to the Norwegian Ministry of Health and Care Services. The scientific 
protocol was finally accepted on the basis of the argument that it would be unfavourable to 
preclude research into dementia on the basis of the lack of an informed consent cause. The 
Norwegian Government supports increased research into geriatrics and patients with 
dementia, because research can enrich the lives of the participants and increase awareness, 
competence and involvement by staff, and it may also improve pain assessment and 
treatment. It is a prerequisite, however, that relatives are able to give presumed consent, 
which refers to an attitude or belief based on reasonable evidence or grounds that have been 
already proven, but that has no value as explicit evidence. It refers to an idea that is taken to 
be true, although it is not known for certain (Tottoczko, 2003). 
In this thesis, verbal and written informed consent was obtained in direct conversation with 
the patient and his or her legal guardian, usually a family member or advocate; collateral 
source consent was required for all patients, given their level of cognitive impairment. The 
study was approved by REK-Vest (no. 190.04), and the Data Inspectorate (no. 11529). 
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REVIEW OF PAPERS 
I Mobilization-Observation-Behaviour-Intensity-Dementia Pain Scale (MOBID):  
Development and Validation of a Nurse-Administered Pain Assessment Tool for 
Use in Dementia 
Husebo BS, Strand LI, Moe-Nilssen R, Husebo SB, Snow AL, Ljunggren AE  
Journal of Pain and Symptom Management 2007:34:67-80. 
 
Background: Pain assessment in older persons with severe dementia is a challenge due to 
reduced self-reporting capacity, and lack of movement-related behavioural pain assessment 
instruments.  
Objectives: To describe the development of the Mobilization-Observation-Behavior-
Intensity-Dementia Pain Scale (MOBID) and to investigate its reliability and validity.  
Methods: Nursing home patients (n=26) with severe dementia were included. Their primary 
caregivers assessed the patients’ pain intensity during regular morning care and using 
MOBID, at the bedside and on the basis of video recordings. External raters completed 
MOBID by rating the videos.  
Results: The internal consistency of MOBID indicated high Cronbach’s alpha (=0.90) after 
deleting the items ‘at rest’ and of ‘teeth/mouth care’. MOBID revealed significantly more 
pain than did pain scorings during regular morning care, and video observation demonstrated 
higher pain intensity than bedside scoring. The inter-rater and intra-rater reliability for 
inferred pain intensity was high to excellent (ICC=0.70-0.96), but varied between poor to 
excellent for pain behaviour indicators (=0.05-0.84).  
Conclusion: The registration of pain behaviour during standardised active, guided 
movements, as performed by the MOBID procedure, is a useful means of arriving at reliable 
and valid pain intensity scores in patients with severe dementia.  
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II Pain behaviour and pain intensity in older persons with severe dementia: 
Reliability of the MOBID Pain Scale by video uptake  
Husebo BS, Strand LI, Moe-Nilssen R, Husebo SB, Ljunggren AE  
Scandinavian Journal of Caring Science2008; in press. 
 
Background: Advancing age is associated with a high prevalence of dementia, often 
combined with under-diagnosed and under-treated pain. The nurse-administered 
Mobilization–Observation–Behaviour–Intensity–Dementia Pain Scale (MOBID) has been 
developed in order to unmask pain during standardised active, guided movements.  
Objectives: To examine the extended intra-rater and inter-rater reliability of pain behaviour 
indicators, inferred pain intensity and the overall pain score.  
Methods: Twenty-six nursing home patients with severe dementia and chronic pain were 
guided by their primary caregivers to perform standardised active, guided movements using 
MOBID while being video recorded. Three external raters assessed the video recordings 
with respect to pain behaviour indicators (Pain noises, Facial expression, Defence) inferred 
pain intensity and the overall pain score, concurrently and independently, on day 1, 4 and 8.  
Results: Facial expression was most commonly observed, followed by pain noises and 
defence. The number of observed pain behaviours increased on repeated assessment, but this 
did not improve reliability. Inter-rater reliability was highest for noises, followed by defence 
and facial expression (=0.44-0.92, =0.10-0.76 and =0.05-0.76, respectively, on day 8). 
The mobilisation of arms and legs was rated most painful. The intra-rater and inter-rater 
reliability of overall pain was very good (ICC 1,1 ranging from 0.92 to 0.97 and 0.94 to 0.96, 
respectively). As opposed to pain behaviour, the reliability of pain intensity scores tended to 
increase on repeated assessment.  
Conclusion: Using video recordings, the MOBID Pain Scale was shown to be sufficiently 
reliable to assess pain in older persons with severe dementia. 
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III Pain in older persons with severe dementia. Psychometric properties of the  
Mobilization–Observation–Behaviour–Intensity–Dementia (MOBID-2) Pain 
Scale in a clinical setting 
Husebo BD, Strand LI, Moe-Nilssen R, Husebo SB, Ljunggren AE. Under review. 
 
Background: In order to assess pain in older persons with severe dementia, a two-part nurse-
administered observational instrument, the Mobilization-Observation-Behaviour-Intensity-
Dementia (MOBID-2) Pain Scale, was constructed and its psychometric properties tested by 
primary caregivers in a clinical setting.  
Objectives: In MOBID-2, the assessment of inferred pain intensity is based on patients’ pain 
behaviour in connection with the standardised, guided movement of different body parts 
(Part 1), and pain behaviour related to internal organs, the head and skin registered on pain 
drawings and monitored over time (Part 2). 
Methods: Patients with severe dementia (N=77) were examined by 28 primary caregivers, 
who concurrently and independently completed the MOBID-2. Characteristics of the 
patients’ pain were also investigated by their physicians (N=4).  
Results: The prevalence of any pain was 81%, with predominance in the musculoskeletal 
system, highly associated with the overall pain score (rho=0.82). Most frequent and painful 
was the mobilisation of the legs. Pain in the pelvis and/or genital region was frequently 
observed. Good to very good inter-rater and test-retest agreement was demonstrated for pain 
behaviour and pain drawings ( = 0.41-0.90 and  = 0.46-0.93), as well as for pain intensity 
(ICC (1,1) ranging from 0.80 to 0.94 and 0.60 to 0.94, respectively). Internal consistency 
was highly satisfactory (= 0.82-0.84). Face-, construct- and concurrent validity were good. 
Overall pain intensity as measured by MOBID-2 was well correlated with physicians’ 
clinical examinations of pain and defined pain variables (rho=0.41-0.64).  
Conclusion: The MOBID-2 Pain Scale was shown to be sufficiently reliable, valid and time-
effective for nurses to assess the localisation, behaviour and intensity of pain in patients with 
severe dementia. 
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IV Who suffer most? Dementia and pain in nursing home patients: A cross-
sectional study  
Husebo BS, Strand LI, Moe-Nilssen R, Husebo SB, Aarsland D, Ljunggren AE.   
Journal of the American Medical Directors Association 2008; in press. 
 
Background: The Mobilization–Observation–Behaviour–Intensity–Dementia (MOBID-2) 
Pain Scale is a novel staff-administered pain tool, developed to assess the location, 
behaviour and intensity of pain in patients with severe dementia. 
Objectives: To explore pain in NH patients and to compare pain relating to different stages 
of dementia, different dementia diagnoses and use of pain medication. 
Methods: In a cross-sectional study, 181 consecutive, long-stay nursing home patients were 
assessed by their 43 primary caregivers, and four physicians. Admission records, 
prescription lists, care plans, Mini-Mental State Examination, Statistical Manual of Mental 
Disorders (DSM-IV), international classification of diseases (ICD-10), cerebral computer 
tomography, pain diagnoses and pain locations from physicians’ examinations, and pain 
intensity measured by MOBID-2 were recorded. 
Results: Patients with severe dementia do not experience less pain intensity (P= 0.079), pain 
diagnoses (P=0.172) and pain locations (P=0.202) compared with other stages of dementia. 
The severely demented patients, who received opioids, demonstrated higher pain intensity 
(mean 4.4, SD 1.7) than non-demented patients (mean 2.9, SD 1.8) (P=0.018), and they 
received less pain treatment. Pain intensity did not differ between diagnostic groups of 
dementia (P=0.439). Patients with mixed dementia who received opioids had more pain 
(mean 5.3, SD 1.5, range 4-7) than mentally healthy controls (P<0.005) and they received 
less pain treatment. 
Conclusion: Patients with different levels and diagnoses of dementia demonstrated the same 
degree of pain characteristics and need for pain medication as non-demented patients, but 
had a higher number of ICD-10 diagnoses. The findings suggest that a comprehensive 
approach to pain treatment in a multidisciplinary perspective is required.  
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MAIN FINDINGS AND SYNOPSIS OF THE PAPERS 
 
The most important findings of this thesis are: 
• Standardised active, guided movements of all body parts as assessed by the MOBID Pain 
Scale and the MOBID-2 Pain Scale Part 1 seem to be of high clinical significance with 
respect to capturing movement-related musculoskeletal pain based on defined pain 
behaviour indicators and inferred pain intensity scores (Paper I).  
• The internal consistency of the MOBID Pain Scale measured by a high Cronbach’s 
=0.90 was arrived at after deleting the items ‘at rest’ and of ‘teeth/mouth care’ (Paper 
I). 
• Facial expression was the most commonly observed pain behaviour indicator, followed 
by pain noises and defence (Paper I). Inter-rater reliability was highest for noises, 
followed by defence and facial expression (=0.44-0.92, =0.10-0.76, and =0.05-0.76, 
respectively, on day 8) (Paper II).  
• The inter-rater and intra-rater reliability for inferred pain intensity for each MOBID item 
and the overall pain score were very good, ICC(1,1) ranging from 0.92 to 0.97 and 0.94 
to 0.96, respectively, on day 8. The reliability of pain intensity scores tended to increase 
on repeated assessment (Paper II). 
• The internal consistency of MOBID-2 was highly satisfactory (Cronbach’s =0.82-0.84). 
Moderate to excellent agreement was demonstrated for pain behaviour and pain drawings 
(=0.41-0.90 and =0.46-0.93, respectively). Inter-rater and test-retest reliability for pain 
intensity was very good (ICC1,1=0.80-0.94 and 0.60-0.94) (Paper III).  
• Through primary caregivers using MOBID-2, 64% of patients were found to have pain 
defined as NRS3.  
• MOBID-2 pain scores demonstrated a predominance in the musculoskeletal system. 
Mobilisation of arms and legs was rated most painful (Paper III).  
• Pain probably originating from the pelvis and/or the genital organs was frequently 
observed as pain from internal organs (Paper III). 
• Indicating concurrent validity, pain intensity scores measured by the MOBID-2 Pain 
Scale were associated with the number of pain diagnoses, locations of pain, analgesic 
treatment and physicians’ pain scores using the NRS (Paper III).  
• Both Part 1 and Part 2 of the MOBID-2 Pain Scale correlated satisfactorily with the 
overall pain score, Part 1 most (rho=0.82), suggesting that pain behaviour occasioned by 
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standardised movements may represent a more concrete pain concept than the 
observation of pain from internal organs, the head and skin (rho=0.61) (Paper III).   
• Patients with severe dementia neither experienced less pain intensity nor had fewer 
diagnoses and locations of pain than those with moderate, mild and no dementia (Paper 
IV). 
• Patients with severe dementia who received opioids as pain treatment were assessed as 
having higher pain intensity than non-demented persons receiving opioids (Paper IV). 
• Pain intensity did not differ in diagnostic groups of demented patients compared with 
non-demented patients, but those with ADVaD who received opioids tended to have 
higher pain intensity than non-demented persons receiving opioids (Paper IV). 
• Findings suggest that NH patients demonstrate a complex picture of suffering, including 
a high number of diagnoses and, possibly, under-treatment of pain, especially in the case 
of severe dementia and ADVaD (Paper IV). 
• The findings of this study provide evidence for the reliability and validity of the newly 
developed MOBID-2 Pain Scale for patients with dementia, and demonstrate that this 
scale can be used reliably in a clinical NH setting (Papers I- IV). 
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DISCUSSION 
GENERAL CONSIDERATIONS  
It was the aim of this thesis to develop a nurse-administered instrument to assess pain in 
patients with dementia and to examine whether this scale is reliable and provides arguments 
for validity. As highlighted in reviewed studies and in this thesis, without a gold standard, 
the validation process for a pain scale is challenging (Stolee et al., 2005; Herr et al., 2006; 
Zwakhalen et al., 2006b; Hadjistavropoulos et al., 2007). Moreover, the testing of validity is 
not only seen as demonstrating the psychometric properties of a scale, it also emphasises the 
characteristics of the people who are assessed (Cronbach, 1971). In this chapter, 
methodological strengths of and limitations on the development and testing of psychometric 
properties of the Mobilization-Observation-Behaviour-Intensity-Dementia (MOBID-2) Pain 
Scale are summarised. The extent to which the limitations have influenced the results is 
discussed in connection with the use of this new scale in a cross-sectional study. 
 
METHODOLOGICAL CONSIDERATIONS 
Reliability, internal consistency 
In Paper I, Cronbach’s  for the initial MOBID procedure, including seven items assessed 
by different raters, ranged from 0.86 to 0.89. When the items ‘at rest’ and ‘teeth/mouth care’ 
were deleted from observation of the patient, Cronbach’s  increased, ranging from 0.90 to 
0.91. The internal consistency of the comprehensive MOBID-2 Pain Scale (Paper III) 
demonstrated a lower Cronbach’s  coefficient (=0.82-0.84). The items for the head and 
skin showed a lower item-total correlation, between 0.20 and 0.35, and it was considered 
whether they should be discarded from the tool. However, using the normal rule of thumb 
formulated by Streiner and Norman, (2006), the items were retained since they had the 
correct item-total correlation of about at least 0.20. These items were seldom scored, with 
little spread in pain intensity and thereby little impact on the -value. Furthermore, it was 
considered important to register pain from all body parts. The internal consistency of the 
MOBID-2 items can also be discussed in light of content or construct validity, which is 
demonstrated through logical presentation of relevant elements (content) of the attribute 
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(pain) being measured (Rothstein and Echternach, 1993). Internal consistency may thus add 
arguments for the selection of relevant elements used to assess pain.  
 
Reliability of pain behaviour 
In Papers I-III, the intra-rater, inter-rater and test-retest reliability of pain behaviour 
indicators were analysed by kappa () statistics. Facial expression was the most frequent 
pain behaviour demonstrated, followed by pain noises and defence. Whereas moderate to 
very good -values were demonstrated for pain noises, the inter-rater reliability for facial 
expression and defence varied between poor and excellent. The analyses in the present study 
were very detailed with respect to both intra-rater reliability and inter-rater reliability, each 
pain behaviour indicator relating to every guided movement being investigated. Usually, 
pain scales assess the occurrence of individual pain behaviour indicators, not related to tasks 
performed. The minute registration involved provides detailed information, which is 
important if patients are to be given adequate treatment. On the other hand, this means that 
reliability is lower than in previous instruments, where ratings are generally coarser. Our 
results also emphasise the caregivers’ interpretation of what pain means to the patient. To 
observe behaviour is important, but its interpretation and conversion into pain intensity is of 
prime importance. It should always be considered and stressed that behaviour may also be 
caused by psychiatric disorders related to dementia 
The intra-rater reliability of pain behaviour indicators did not increase on repeated 
measurement (Paper II), and -values were actually somewhat lower during test-retest 
examination (Paper III). Domholdt (2005) emphasised the challenge of reproducing 
measurements of pain, because pain is a changing phenomenon. Comparing the assessment 
of pain behaviour indicators during video recordings with bedside examination, it was 
unexpectedly found that nurses observed less pain behaviour in a clinical setting, but 
obtained good inter-rater reliability and even better test-retest reliability (Papers I-III). This 
makes sense, because the ‘hands on’ situation and the patient-caregiver dyad at the bedside 
may have a central impact on the individual’s interpretation of pain behaviour. Several 
studies used video recordings to validate the psychometric properties of pain assessment 
instruments (Snow et al., 2004b; Defrin et al., 2006; Zwakhalen et al., 2006b). One can 
speculate, however, that scoring by video recording overestimates pain observations, or that 
‘hands on’ situations underestimate them. Further research is needed to determine which 
testing situation is most valid.  
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Reliability of pain intensity 
In Papers I-III, the intra-rater, inter-rater, and test-retest reliability of pain intensity of each 
MOBID and MOBID-2 item, as well as the overall pain intensity, were analysed using 
ICC(1,1) statistics. Each aspect of the analysis demonstrated high to excellent reliability of 
pain intensity in the MOBID and the MOBID-2 Pain Scale, both using video recordings and 
during bedside examinations. In connection with the challenge of judging pain from internal 
organs and the skin, the MOBID-2 Part 2 demonstrated somewhat lower reliability scores. In 
addition, lower test-retest values reflect the fact that a second cause of variability is 
introduced, when the test is repeated over time, simply due to a change in pain, a change in 
the test situation or in the mood of the patient (Domholdt, 2005). We concluded in Papers I-
III that there may be a connection between the actual observation and the interpretation of 
the whole care situation. This confirms earlier results that the observer must be familiar with 
the patient and his usual behaviour (Morello et al., 2007). Reviews of pain assessment scales 
for persons with dementia have to be interpreted in the context of the patient-proxy dyad, 
and observations at rest or during activities. Such examinations may give rise to or alleviate 
pain, and behaviour may be typical of pain, but also of dementia. Some existing scales 
investigate reliability in terms of pain behaviour, others in terms of intensity, while yet 
others combine both. We found no studies explicitly distinguishing between observed pain 
behaviour and pain intensity, as is the case in the present thesis. 
Our findings demonstrate a number of other, more subtle elements of the pain 
communication process. We found that reliability was particularly high in the overall score 
of pain intensity, but it was also satisfactory for the individual movements. However, the 
reliability of the pain behaviour indicators was not generally high. This seems to contradict 
the idea that high reliability of pain behaviour indicators is a prerequisite for adequate 
reliability of inferred pain intensity. It is considered most important to discover whether the 
patient is in pain and also where it hurts in order to begin a process of treating the pain. 
Perhaps the intensity of pain behaviour, rather than the number of pain behaviours, is most 
important as a basis for scoring pain intensity. The importance of the specified pain 
behaviours may simply be that it increases awareness of pain expressions. 
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Reliability of pain drawings 
As a central part of any thorough pain evaluation, pain drawing is the instrument most 
commonly applied to register pain location (Jensen and Karoly, 2001). Moderate to high 
reliability of pain drawings has previously been demonstrated in cognitively intact people 
(Margolis et al., 1988). MOBID-2 is the first pain scale for demented persons where proxies 
are encouraged to use a pain drawing to suggest the location of pain, based on behavioural 
observations. In Paper III, about 40% of the raters documented their observations on pain 
drawings. The highest number of crosses for pain was observed in the pelvis and genital 
organs, and lowest for the skin. Moderate to good inter-rater reliability was shown for pain 
drawings, as well as good test-retest reliability, particularly for the pelvis and genital organs.  
 
Validity 
One of the most difficult aspects of validity testing is the terminology, including face 
validity, construct, and concurrent validity (Streiner and Norman, 2006). There is no simple, 
absolute, direct test of validity, and there is a risk of thinking of a measurement as being 
either valid or invalid. Almost all measurements contain some information. The word 
(concept) validity is not an all-or-nothing concept. Research evidence can add arguments for 
validity, but it can never directly or absolutely test whether all relevant elements are 
reflected in the measurement (Rothstein and Echternach, 1993). The validity of a pain 
measurement has to be debated, particularly, in the case of a proxy rating a demented 
patient’s pain problems. Given the lack of alternative measurements, this approach is an 
important one. 
 
Validity of the MOBID-2 items 
As patients tend to avoid painful movements, an approach involving obligatory, standardised 
active, guided movements adds new and important aspects to the assessment of pain in 
dementia. In line with our presumption, higher overall pain scores (p<0.005) were registered 
using the MOBID procedure than after regular care activities (Paper I). Support was thus 
provided for construct validity. Other pain scales such as the CNPI, ADD, Doloplus-2, 
NOPPAIN and ECPA encourage the raters to observe the patient during everyday activities. 
However, since these measures do not require a standardised movement protocol, pain 
  
43 
behaviour may not be revealed, as pain tends to change the way activities are performed 
(Magnussen et al., 2004). Patients may even avoid moving completely if it hurts.  
The use of active, guided movements was debated during development of the MOBID Pain 
Scale, as this approach may be more pain-provoking than naturally occurring activities. The 
presence of pain contributes to a pain circle, in which less mobilisation of the patient causes 
muscle hypotrophy, contractures and often more pain. The ethics of the primary caregivers 
provoking pain may be questioned. The aim of the MOBID or the MOBID-2 procedure is 
not to provoke unnecessary pain, but to identify the problem. The pain-provoking movement 
is reversed immediately whenever pain behaviour is perceived. In this way staff may 
contribute to revealing pain in demented patients, which is a prerequisite for pain 
management. 
With respect to face validity (Paper I), the focus group requested that items should not only 
be related to the musculoskeletal system, but also to visceral and neuropathic pain and 
headache syndromes. As one of the first pain scales for patients with dementia, MOBID-2 
Part 2 included the assessment of behaviour that might be related to pain from internal 
organs, the head and skin (Paper III). The focus group underlined that the judgement of a 
demented patient’s pain experience will always be challenging, especially when pain stems 
from the head, internal organs and skin. Caregivers are neither skilled nor authorised to 
investigate these areas. In order to capture such pain, the observation of pain behaviour 
should probably be monitored by the caregivers over time. It should be a prerequisite that the 
rater is familiar with the patient’s usual behaviour. The focus group maintained that 
MOBID-2 seemed well-suited to identifying the prevalence of pain related to the 
musculoskeletal system and internal organs by a caregiver who knows the patient. 
The ADD and the Abbey pain scales encourage the rater to assess pain from internal organs. 
These scales are not based on defined pain behaviour, do not include skin problems, which 
are frequent health problems in the NH, and do not discriminate between pain from the 
musculoskeletal system and other types of pain. Investigating construct validity, it was 
demonstrated that items in both Part 1 and Part 2 were satisfactorily correlated with the 
overall pain score. However, MOBID-2 Part 1 items were more highly associated with the 
overall pain intensity scores (rho=0.82) than Part 2 items (rho=0.61). This makes sense 
because the prevalence of nociceptive pain (NRS3=58%) was more frequently observed 
than pain probably originating from internal organs or the skin (NRS3=42%) (Paper III). 
Moreover, pain behaviour caused by standardised movements may cause a more immediate 
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pain reaction than the pain behaviour emanating from internal organs, the head and skin, 
monitored over time. 
One major consideration in item selection is the desire for specificity versus sensitivity. 
MOBID-2 is a time-effective pain scale that includes 10 items. It was considered by the 
focus group to be relevant, manageable, motivating and feasible for staff in a clinical setting. 
Shorter tools include limited indicators, but, if present, they may be more likely to accurately 
recognize pain. Longer and more comprehensive instruments are also recommended, 
possibly capturing more pain behaviour, although some patients may be identified whose 
behaviour is not caused by pain (Hadjistavropoulos et al., 2007). In a validation study of 
PACSLAC, DOLOPLUS-2, and PAINAD, caregivers judged the PASCLAC to be clinically 
useful (Zwakhalen et al., 2006b). However, to answer 60 questions in five minutes seems to 
be challenging the case of patients with dementia. Time-consuming assessments and 
personal compliance is little discussed in the context of stressful NH routines, but feasibility 
is mandatory for an assessment tool to be used in the clinic. 
 
Validity of pain behaviour  
The MOBID and MOBID-2 Pain Scale include three key indicators of pain behaviour (Pain 
noises, Facial expression, Defence) accompanied by 12 explanatory words. In Paper I-III, 
facial expression was the most frequently observed pain behaviour indicator, followed by 
pain noises and defence. The number of observed pain behaviours (independent variable) 
was shown to significantly influence the staff’s interpretation of pain intensity (dependent 
continuous variable) (p<0.005). When no pain behaviour was observed, no pain intensity 
was registered, while an increasing number of pain behaviour indicators caused increased 
pain intensity scores with a linear trend (Paper I). Another aspect of construct validity was 
indicated, as the overall pain intensity scores measured by the MOBID Pain Scale were 
shown to be higher when scored from video rating than from bedside observation (P<0.001), 
although the scores were highly correlated (rs=0.67). The results underline that important 
pain behaviour indicators may be overlooked during bedside observation. It was 
unexpectedly found that the maximum pain intensity scores among all the MOBID items 
demonstrated a higher correlation with the overall pain intensity (r.92) than the mean pain 
intensity of all items (r.86). This makes sense, as it is probably less important for a patient 
to be pain-free in, e.g. his knees when he is struggling with serious back pain, because the 
back pain will dominate his overall pain experience. 
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The interpretation of pain behaviour indicators is challenging. According to Ekman and 
Friesen (1982), observers are able to discriminate between seven facial expressions of 
emotion. In this list, pain is not included as an isolated and unique expression, but is related 
to the expression of fear (Ekman, 1993). As such, fear may be an indicator of both 
psychological challenge and pain. Thus, questions could be raised about the sensitivity and 
specificity of facial expression for the purpose of pain assessment. Furthermore, several 
indicators of pain, such as restlessness, depression, isolation and aggression, can be observed 
in connection with behavioural disturbances caused by dementia. In the absence of a gold 
standard, this methodological challenge has been discussed in recent years. The earliest 
attempts to quantify pain using behavioural observation suggested that a protocol should be 
followed in which patients were asked to perform a series of behaviours during which they 
were videotaped (Keefe and Block, 1982). Raters then scored the presence or absence of 
specific behaviour in timed sequences. Such approaches are cumbersome in a clinical 
setting, but very useful for research purposes in relation to testing the reliability and validity 
of a behavioural tool. 
To examine the validity of a behavioural pain scale, the total scores of previously developed 
instruments were correlated with a visual analogue scale (VAS) or other intensity scale filled 
in by a proxy. However, we could not find previous reports with detailed validity testing of 
separate pain behaviour indicators, as performed in Paper I. This is of key importance, since 
patients with dementia may not present any pain behaviour caused by physical impairment. 
On the other hand, pain influences behavioural disturbances among those with severe 
dementia more often than among those with moderate or mild dementia, and residents with 
chronic pain who have severe dementia exhibit significantly more dysfunctional behaviour 
than those with earlier-stage dementia (Cipher et al., 2006). It remains to be seen whether, 
instead of using a proxy report approach, it could be an option to use a selected group of 
elderly people with the ability to self-report their pain, as an alternative strategy aimed at 
further validating behavioural indicators. However, the scoring of pain behaviour indicators 
depends largely on the proxy rater’s awareness of pain, which may be a useful option. 
We did not include more subtle non-verbal indicators, such as changes in interpersonal 
interaction, mental status, activity patterns and routines, as recommended by the American 
Geriatrics Society (1998). While considered interesting, we question whether it is possible to 
distinguish between  psychiatric disturbances related to dementia, pain behaviour and 
behavioural changes. Functional items such as sleep, appetite and social contact are affected 
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by pain, but they may also depend on a large number of other factors. Rare use of these items 
has been demonstrated, as well as low reliability and validity (Holen et al., 2005; Zwakhalen 
et al., 2006b).  
 
Validity of pain intensity scores 
Norm referencing may be another aspect of validity. It describes how a scale relates to a 
correct judgement from a representative sample of the population (Rothstein and Echternach, 
1993). In the MOBID and MOBID-2 Pain Scale, a new concept was presented, as observed 
pain behaviours were inferred to pain intensity. This interpretation of whether behaviour is 
related to pain or dementia also reflects the observers’ individual experience and attention. 
The most frequently occurring, and with highest pain intensity, was mobilisation of the legs, 
in line with the diagnosis from the patients’ medical records. This is also in line with primary 
health care studies, where pain related to knees and shoulders is considered to be a frequent 
complaint (Mantyselka et al., 2001), as is pain from the pelvis/genital organs and irritable 
bowel syndrome (Chaplin et al., 2000). However, cardiovascular disorders, a frequent health 
problem in the elderly (Crepaldi and Scognamiglio, 2000), were seldom assessed by the 
MOBID-2 Pain Scale. This may be explained by a defective ischemia warning system or 
lack of typical symptoms in connection with angina pectoris (Cohn et al., 1999). In MOBID-
2 Part 2, the observation of pain behaviour monitored over time (today or during the last few 
days, week) is recommended. Perhaps a more detailed description of pain behaviour related 
to internal organs, the head and skin would be a better concept. However, the expression of 
pain related to these areas is individual, depending on the nature and duration of pain.  
In Paper III, support was provided for the concurrent validity of the MOBID-2 Pain Scale, 
as there was an association between the overall pain intensity assessed by nurses and other 
pain variables (number of pain diagnoses, pain locations and pain medications) assessed by 
physicians. Furthermore, the overall MOBID-2 pain intensity scores were related to the 
intensity score assigned by physicians using the NRS. These are satisfactory results, as these 
measures represent different aspects or indicators of pain intensity. Paper IV also provided 
arguments for concurrent validity, as pain characteristics and baseline measurements were 
compared between groups of pain medication and pain diagnoses (P=0.001), pain 
localisations (P=0.001), MOBID-2 overall pain intensity (P=0.001), Part 1 (P=0.001) and 
Part 2 (P=0.001).  
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The use of the 0-10 numerical rating scale (NRS) to rate the pain intensity of each MOBID-2 
item and the overall pain scores can be debated, as no information has been published about 
the distribution of its measurement error (Williamson and Hoggart, 2005). This scale is a 
well accepted disease-specific measure of pain intensity and it has been used successfully in 
a number of recent chronic pain drug studies (McQuay, 2005). In addition, the NRS has been 
found to be very responsive to changes in pain, even more so than the VAS. The satisfactory 
responsiveness to change indicates that its measurement error is within acceptable levels 
(Bolton and Wilkinson, 1998). 
 
Validity of pain drawings 
Caution must be exercised not to over-interpret pain drawings from proxy raters in patients 
with dementia. As pain from internal organs, the head and skin may be difficult to identify, 
and caregivers are not authorised to perform clinical examinations, one main effect of pain 
drawing could be to increase the caregivers’ awareness of the patient’s pain. Only simple 
crosses were used to suggest pain location in the present study. In cognitively intact people, 
shading the area of pain extension would provide better information. To obtain more detailed 
boundaries for pain extension via proxies seemed unrealistic. It may be difficult to 
discriminate between pain originating from the abdomen or the pelvis. Merging these two 
items could simplify the scoring. Furthermore, 19% of the assessed patients had marks on 
pain drawings related to the musculoskeletal system, especially the extremities (Paper III). 
In connection with scoring MOBID-2 Part 1, raters may still be focused on these pain sites, 
and therefore also mark the observed pain on the body chart. Moreover, referred pain from 
internal organs (e. g. heart, gallbladder, bladder) may stimulate corresponding dermatomes 
(Nurmikko, 1995; Higa et al., 1997; Petchkrua and Harris, 2000; Inoue et al., 2006). 
Unfortunately, research into the projection of pain from visceral diseases onto pain 
dermatomes is rare in elderly people with dementia. 
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THE MOBID-2 PAIN SCALE IN A CLINICAL SETTING 
After the psychometric property testing of the MOBID-2 Pain Scale (Paper I-III), the pain 
scale was used to test the hypothesis that the amount of pain characteristics (diagnoses, 
location and intensity of pain) and pain medications decreases as levels of dementia increase, 
and that pain intensity differs between subjects with different dementia diagnoses (Paper 
IV). These hypotheses were based on studies suggesting that patients’ ability to report pain 
decreases as cognitive impairment increases  (Huffman and Kunik, 2000), and that patients 
with dementia may experience less pain perception and higher tolerance of experimental 
pain (Scherder et al., 2001; Benedetti et al., 1999).  
Contrary to the hypothesis, we found that pain characteristics and the number of pain 
medications were not associated with the severity of dementia. Patients with severe dementia 
neither experienced less pain intensity nor had fewer diagnoses and locations of pain than 
those with moderate, mild and no dementia. In addition, pain intensity did not differ in 
diagnostic groups of demented patients compared with non-demented patients. Indeed, 
patients with severe dementia and ADVaD who received opioids tended to have even higher 
pain intensity scores as measured by the MOBID-2 Pain Scale than non-demented persons 
receiving opioids. 
These results are consistent with those of Cole and colleagues (Cole et al., 2006) who found 
that AD patients showed greater amplitude and duration measured by functional brain 
imaging than controls, as a response to noxious stimuli. It was also suggested that disruption 
caused by white-matter lesion may increase pain experience by deafferentiation in patients 
with VaD compared with AD (Melzack, 1999). Pain experience involves many pain 
components related to the lateral and medial pain system. These areas may be affected in AD 
and VaD, leading to changes in pain processing (Scherder et al., 2003b; Scherder et al., 
2002; Scherder et al., 2003a). In contrast to acute pain caused by stimulation during fMRI 
performance, elderly patients suffer from chronic pain (Miro et al., 2007), which is 
associated with decreased regional cerebral blood flow (Peyron et al., 2000). It remains a key 
question whether results from fMRI can be transferred to clinical observations and individual 
consequences for the individual patient. 
Our data strongly suggest that patients with ADVaD are more distressed by increased pain 
intensity than are non-demented patients. One possible explanation for this may be that 
infarction of the brain may occur in many locations and influence all dimensions of pain 
(Scherder et al., 2003a). A high prevalence of pain combined with communicative 
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disabilities may therefore lead to a despairing situation for these patients. Cipher and 
colleagues (2006) suggested that pain influences behavioural disturbances among those with 
severe dementia more often than among those with moderate or mild dementia, and residents 
with chronic pain who have severe dementia exhibit significantly more dysfunctional 
behaviour than those with earlier-stage dementia (Cipher et al., 2006). 
If pain experience is increased in mixed and severe dementia, the reduced prescription of 
pain medication (Morrison and Siu, 2000; Frampton, 2003; Nygaard et al., 2003; Nygaard 
and Jarland, 2005; Hutt et al., 2006) and the potential reduced effect of such drugs in patients 
with dementia (Benedetti et al., 2006) would mean that pain is undertreated, resulting in 
increased suffering in this frail population. In the present study (Paper IV), the total number 
of pain medications did not differ according to different levels of dementia and dementia 
diagnoses, suggesting a comparable need for pain treatment. The reason why patients with 
severe dementia (24%) and ADVaD (9%) did not receive the same amount of  opioids as 
non-demented elderly persons (37%) could be a wish to avoid side effects (Pickering et al., 
2001). Older people are more likely to experience the side effects of analgesic medications, 
and they appear to be more sensitive to analgesic properties, especially those of opioid 
analgesics (Dahl, 1996; Pickering et al., 2001). However, we found no studies investigating 
opioid side effects in patients with dementia.   
Our results may also be explained by the staff’s over-interpretation. Care providers who are 
interested in pain assessment in dementia and have long work experience participated in this 
study. To assess a patient’s pain and observe him while interpreting pain behaviour is 
demanding and may be a psychological burden. Visual impressions of patients’ suffering 
may lead to increased pain intensity scores. The fact that this NH has a palliative care unit 
with physicians and caregivers skilled in pain treatment might have influenced the findings. 
The use of opioids in general did not seem to be restricted, since a high percentage of 
mentally healthy controls received opioids as pain treatment. The fact that patients with 
ADVaD, in particular, received less opioids may be due to the fact that it is difficult to 
capture pain behavioural expressions in this group of patients. It does not seem to be 
sufficient to be generally competent in pain assessment and treatment; competence should 
also include pain in dementia. 
Our results may also be explained by the staffs  ` over interpretation. Care providers, 
interested in pain assessment in dementia and with long working experience, participated in 
this study. To assess the patient’s pain and observe him while interpreting pain behaviour is 
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demanding and may represent a psychological burden. Visual impression by patients 
suffering may lead to increased pain intensity scores. The fact that this NH has a palliative 
care unit with physicians and caregivers skilled in pain treatment, might have influenced the 
findings. The use of opioids in general did not seem to be restricted, since a high percentage 
of mentally healthy controls received opioids as pain treatment. Why patients with ADVaD 
received less opioids, in particular, may be due to difficulty of capturing pain behavioural 
expressions in this group of patients. It seems not sufficient to be generally competent in 
pain assessment and treatment; competence should also include pain in dementia. 
Pain assessment in dementia is complex, but the patients’ pain characteristics and need for 
pain relief seem to be comparable with mentally healthy controls. At all levels of dementia 
and in VaD and ADVaD, the increased prevalence of ICD-10 diagnoses may contribute to 
increasing the patients’ suffering. We suggest that patients received less pain relief than they 
needed, and that an isolated increase of opioids may be limited by a high prevalence of ICD 
diagnoses and opioid side effects. The patients’ multi-morbidity and lack of communicative 
ability suggest the need for a comprehensive approach to pain assessment and treatment in a 
multidisciplinary perspective. More research and quality improvement programmes are 
needed regarding pain assessment and pain management in dementia.  
The classification of dementia etiology groups was based on physicians’ clinical 
examinations, screening of dementia and cCT. This classification may be attenuated by 
underlying subtle brain processes which can only be clarified by autopsy. 
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CHRONIC VERSUS ACUTE PAIN 
It may be a limitation of this thesis that a differentiation has not been accomplished between 
acute and chronic pain behaviour. Such differentiation is normally of key importance, since 
the duration of pain has a high impact on the expectation of pain treatment (Turk and 
Okifuji, 1999), and 94% of elderly persons with pain in the Mediterranean region of 
Catalonia experience chronic pain (Miro et al., 2007). Breivik et al. (2006) demonstrated an  
overall prevalence of moderate to severe chronic pain in the general adult population of  15 
European countries and Israel of 19%. About 40% of the respondents suffering from chronic 
pain were not satisfied with the effect of treatment. Many aspects of everyday life, working 
life, somatic, emotional and social wellbeing were described to be affected (Breivik et al., 
2006). However, the oldest, the sickest, and those living in NHs were not included in this 
survey (Breivik et al., 2006).  
It is a challenge to choose a pain stimulus which provides an opportunity to observe patients 
with a reasonable level of pain. Acute pain stimulation in the form of influenza vaccination 
has been used to test existing pain assessment instruments (Defrin et al., 2006; Zwakhalen et 
al., 2006b). Such a model will test acute pain, but lack relevance to clinical situations for 
cognitively impaired patients with chronic pain in NHs. Future research must investigate 
relevant methodological approaches, and whether acute pain behaviour during vaccination 
stimuli is congruent with chronic pain behaviour provoked by standardised movements. 
Further research is also needed to investigate the responsiveness of the MOBID-2 Pain 
Scale, which is an important issue in terms of reflecting changes in pain experience after 
treatment. Responsiveness is related to both the reliability and validity of the measure. If a 
measure is not very reliable, then changes in scores must be large if they are to represent 
more than measurement errors (Domholdt, 2005). Such a study should include an open 
systematic pain medication study (with respect to dementia) as well as different treatment 
routes (e.g. antibiotics, nitro-glycerine) (Cohen-Mansfield and Lipson, 2007). 
 
EXTERNAL VALIDITY 
External validity deals with the possibility to generalize the test results of the MOBID-2 Pain 
Scale to other populations than participants of the present study (Domholdt, 2005). Our 
findings are based on data from only one NH, and external validity regarding other NHs 
might be questioned, as pain assessment, pain treatment and conditions for the staff may be 
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different. As most of the patients were admitted to the NH from primary health care and 
hospitals, patients included in the study could reflect the frequency of pain problems in 
elderly patients in general. The fact that the included patients were admitted to the NH, 
indicated that they were more severely ill than patients in the same age with the same 
diagnoses treated at home. Compared to them, NH patients may have more clinical risk 
factors, for instance immobility caused by stroke, and thus a higher probability of having 
pain. Therefore, one should be cautious about general extrapolation of the study finding to 
primary care. In addition, a more severely ill patient might also be expected to develop more 
drug-related interactions related to opioid analgesics or NSAIDs.  
The psychometric properties of the MOBID and the MOBID-2 Pain Scale were tested in 
patients with severe dementia. Additionally, the MOBID-2 was used to assess the behaviour, 
intensity, and location of pain in patients with different levels and diagnoses of dementia in a 
clinical setting (Paper IV). We did not examine the usefulness of the scale regarding 
patients with moderate and mild dementia, or dying patients with reduced consciousness. 
This should be of future interest, as a systematically approach of the MOBID-2 Pain Scale 
may be of interest in these patients.  
 
ETHICS AND APPROVALS 
The process of obtaining ethical approval from the responsible Norwegian government body 
in accordance with applicable legislation for including patients with dementia in this study 
was a laborious one, although of key importance. According to the Declaration of Helsinki, 
the approval of a research ethics committee is needed for every scientific study on patients 
(Carlson et al., 2004). There has to be a balance between the obligation to protect the patient, 
on the one hand, and the possibility of increasing patients’ quality of life through new 
research results, on the other. 
Special precautions are necessary in connection with research on patients with cognitive 
impairment, if they are judged to be potentially incapable of consenting (Margiotta et al., 
2002). For a research subject who is under legal guardianship, pursuant to applicable 
legislation, the investigator must obtain informed consent from the legally authorised 
representative in accordance with applicable law. Generally, mentally incompetent people 
should not be included in research unless the research is necessary in order to promote the 
health of the population represented, and this research cannot be performed on legally 
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competent persons. Moreover, research on individuals from whom it is not possible to obtain 
consent should only be performed if their physical and mental condition is a necessary 
characteristic of the research population.   
As regards studies in patients with dementia, researchers themselves play a particularly 
important role, because they have to judge whether or not a potential participant is capable of 
consenting. Research has shown that the diagnosis of dementia does not necessarily mean 
that a patient is incapable of making a decision about not to take part in a clinical study 
(Karlawish et al., 2002). Across Europe, the protection of research subjects with dementia 
has to satisfy a variety of national legalisation and ethical codes. Including 12 countries, one 
study demonstrated the differences in strategies between medical ethical committees  with 
respect to informed consent and capacity to consent (Rikkert et al., 2005).  
As is the case in researching a good death, practical, ethical and methodological difficulties 
have to be overcome. Kendall and colleagues (2007) concluded that many patients 
approaching the end of life wish to participate in research, because research can enrich the 
lives of participants and enhance the dignity of patients. Patients with severe dementia would 
seem to be incapable of giving informed consent to participation in a research study, and 
they have to be protected against research projects that might be harmful (Margiotta et al., 
2002). However, the lack of openness in society about attitudes to ageing and dementia may 
act as a barrier to dementia research, leading to the exclusion of these patients. Yet such 
research is essential. The research process must be conducted with ethical and 
methodological rigour and in ways that support the patients, their relatives, and the staff. 
Committees of ethics and clinicians must balance their concerns about non-maleficence 
against presumed consent by relatives or the autonomy of people to participate if they wish.  
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SUMMARY AND CONCLUSION 
In most countries, the population of individuals over the age of 65 years is increasing, and 
thereby the prevalence of dementia. Advancing age is also associated with increased 
prevalence of pain, often caused by musculoskeletal conditions, pain from internal organs or 
neuropathies. Thus, many elderly, living at home or in long-term care settings, experience 
both dementia and pain. The measurement of pain in these patients remains a challenge, 
caused by a decreased or absent capacity to self-report due to deficits in language, memory, 
and abstract thinking inherent to this disease.  
The Mobilization-Observation-Behaviour-Intensity-Dementia (MOBID-2) Pain Scale is a 
two-part nurse-administered observational instrument aimed at assessing pain in patients 
with dementia. In MOBID-2, inferred pain intensity is based on patients’ pain behaviour 
during standardised, guided movements of different body parts (Part 1), and pain behaviour 
related to internal organs, the head and skin (Part 2). Internal consistency measured by 
Cronbach’s alpha was highly satisfactory. The inter-rater and test-retest reliability for pain 
intensity was very good. Arguments for face-, construct- and concurrent validity were 
provided, as MOBID-2 pain scores were correlated with physicians’ examinations and other 
parameters of pain. 
Using MOBID-2 in a cross-sectional study, pain characteristics and the number of pain 
medications were not found to be associated with severity of dementia. Patients with severe 
dementia neither experienced less pain intensity nor had fewer diagnoses and locations of 
pain than those with moderate, mild and no dementia. Patients with severe dementia and 
ADVaD who received opioids as pain treatment were assessed as having higher pain 
intensity than non-demented persons receiving opioids.  
It was concluded that pain assessment in dementia is a complex issue. The judgement of a 
demented patient’s pain experience by a proxy rater will always be challenging, especially 
when the pain stems from the head, internal organs or skin. Certainly, the validity of pain 
intensity scores can be questioned, and they should be substantiated by physicians who can 
perform thorough examinations. Finally, the results of this thesis are based on data from only 
one NH, and external validity in relation to other NHs must be examined in future research, 
since pain assessment, pain treatment and conditions for the staff may be different. 
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IMPLICATION AND FURTHER RESEARCH 
The development and psychometric property testing of the MOBID-2 Pain Scale has not yet 
been accomplished. The following steps will be included in future research:  
1. examining the usefulness of the instrument in assessing acute as well as chronic pain, 
related to pain duration 
2. further assessing the concurrent validity of the MOBID-2 by comparing the scale with 
other pain scales for patients with dementia 
3. investigating the responsiveness of the scale in an open intervention study  
4. using MOBID-2 in different clinical settings  
When working with the concept of MOBID-2, we experienced that healthcare professionals 
showed an interest in the framework and results of this thesis. Both standardised training in 
pain assessment and treatment in dementia and the translation and testing of the MOBID-2 
Pain Scale into different languages was required. In the present study, the participating 
caregivers’ awareness, competence and interest seemed to increase noticeably, underlining 
the need for implementation of research results in NHs. Assessing the presence, intensity, 
etiology and medication of pain in Norwegian NH patients, as well as the education of the 
caregivers will be a natural consequence of this thesis. 
To obtain more knowledge about the relationship between pain and behavioural disturbances 
in dementia, research will be undertaken to systematically follow elderly persons with 
dementia at home and in the NH. Efforts should be made to assess whether pain management 
and physiotherapy can improve behavioural disturbances in these patients. 
Our study provided evidence that patients with severe dementia do not experience less pain 
intensity or fewer pain diagnoses and pain locations than patients in other stages of 
dementia. On the contrary, patients with severe dementia and ADVaD risk suffering more 
pain than other groups of demented and cognitively intact people. At this stage of the 
research, it seems natural to explore the underlying brain correlates of pain in patients with 
AD, with and without chronic pain as measured by fMRI. In addition, questions arise about 
whether the genetic contributions to pain are also apparent in patients with dementia. 
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Most of all, research into patients with dementia has to be supported in order to increase the 
focus on and interest in these weak patients, their relatives and caregivers. Our findings 
suggest that NH patients demonstrate a complex picture of suffering due to multi-morbidity 
and lack of communicative ability. The implementation of our research results has to be 
guaranteed in NHs, at home and in hospitals. Then, research will contribute to greater 
competence, reflection and development processes. For the sake of patients with dementia, 
their relatives and the staff, we hope that this thesis will help to create a basis for more 
dignity and an improvement in the quality of care in the NH, as well supporting research in 
Primary Health Care. 
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